Header

UZH-Logo

Maintenance Infos

Publications for Moch, H

Navigate back| Up a level
Export as
Group by:
Number of items: 434.

2018

Rulle, Undine; Tsourti, Zoi; Casanova, Ruben; Deml, Karl-Friedrich; Verbeken, Eric; Thunnissen, Erik; Warth, Arne; Cheney, Richard; Sejda, Aleksandra; Speel, Ernst Jan; Madsen, Line Bille; Nonaka, Daisuke; Navarro, Atilio; Sansano, Irene; Marchetti, Antonio; Finn, Stephen P; Monkhorst, Kim; Kerr, Keith M; Haberecker, Martina; Wu, Chengguang; Zygoura, Panagiota; Kammler, Roswitha; Geiger, Thomas; Gendreau, Steven; Schulze, Katja; Vrugt, Bart; Wild, Peter; Moch, Holger; Weder, Walter; Ciftlik, Ata Tuna; et al (2018). Computer-based intensity measurement assists pathologists in scoring PTEN immunohistochemistry - Clinical associations in NSCLC patients of the ETOP Lungscape cohort. Journal of Thoracic Oncology, 13(12):1851-1863.

Rindi, Guido; Klimstra, David S; et al; Moch, Holger (2018). A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Modern Pathology, 31(12):1770-1786.

Banz, Yara; Berezowska, Sabina; de Leval, Laurence; Rubbia-Brandt, Laura; Tolnay, Markus; Moch, Holger; Perren, Aurel; Hewer, Ekkehard (2018). Advancing synoptic cancer reports beyond English: the University of Bern/PathoLink approach. Virchows Archiv, 473(5):655-656.

Velagapudi, Srividya; Schraml, Peter; Yalcinkaya, Mustafa; Bolck, Hella Anna; Rohrer, Lucia; Moch, Holger; von Eckardstein, Arnold (2018). Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma. Journal of Lipid Research, 59(11):2188-2201.

Delahunt, B; Srigley, J R; Judge, M J; Amin, M B; Billis, A; Camparo, P; Evans, A J; Fleming, S; Griffiths, D; Lopez-Beltran, A; Martignoni, G; Moch, H; Nacey, J N; Zhou, M (2018). Dataset for the reporting of carcinoma of renal tubular origin: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology:Epub ahead of print.

Binder, Carmen; Matthes, Katarina Luise; Korol, Dimitri; Rohrmann, Sabine; Moch, Holger (2018). Cancer of unknown primary-Epidemiological trends and relevance of comprehensive genomic profiling. Cancer Medicine, 7(9):4814-4824.

Williamson, Sean R; Rao, Priya; Hes, Ondrej; Epstein, Jonathan I; Smith, Steven C; et al; Moch, Holger (2018). Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists. American Journal of Surgical Pathology, 42(9):1253-1261.

Zhong, Qing; Wagner, Ulrich; Kurt, Henriette; Molinari, Francesca; Cathomas, Gieri; Komminoth, Paul; Barman-Aksözen, Jasmin; Schneider-Yin, Xiaoye; Rey, Jean-Philippe; Vassella, Erik; Rogel, Uwe; Diebold, Joachim; McKee, Thomas; Jochum, Wolfram; Kashofer, Karl; Hofman, Paul; Zischka, Melanie; Moch, Holger; Rechsteiner, Markus; Wild, Peter J (2018). Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing. Pathology, Research and Practice, 214(7):957-963.

Gramatzki, D; Roth, P; Rushing, E J; Weller, J; Andratschke, N; Hofer, S; Korol, D; Regli, L; Pangalu, A; Pless, M; Oberle, J; Bernays, R; Moch, H; Rohrmann, S; Weller, M (2018). Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study. Annals of Oncology, 29(6):1431-1436.

Vital, Domenic; Ikenberg, Kristian; Moch, Holger; Roessle, Matthias; Huber, Gerhard F (2018). The expression of the cancer testis antigen MAGE A4: A favorable prognostic biomarker in salivary gland carcinomas related to low tumor grading. Laryngoscope Investigative Otolaryngology, 3(3):182-190.

Tuma, Jan; Moch, Holger; Stuckmann, Gerd; Gysel, Walter; Serra, Andreas L (2018). Two in One: Epithelioid angiomyolipoma within a classic kidney angiomyolipoma - a case report. BMC Nephrology, 19(1):123.

Roswall, Pernilla; Bocci, Matteo; Bartoschek, Michael; et al; Moch, Holger (2018). Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling. Nature Medicine, 24(4):463-473.

Moch, Holger; Ohashi, Riuko; Gandhi, Jatin S; Amin, Mahul B (2018). Morphological clues to the appropriate recognition of hereditary renal neoplasms. Seminars in Diagnostic Pathology, 35(3):184-192.

Keller, Nadia; Andreoni, Federica; Reiber, Claudine; Luethi-Schaller, Helga; Schuepbach, Reto Andreas; Moch, Holger; Maggio, Ewerton Marques; Zinkernagel, Annelies Sophie (2018). Human Streptococcal Necrotizing Fasciitis Histopathology Mirrored in a Murine Model. American Journal of Pathology, 188(7):1517-1523.

Velizheva, Nadezda P; Rechsteiner, Markus P; Valtcheva, Nadejda; Freiberger, Sandra N; Wong, Christine E; Vrugt, Bart; Zhong, Qing; Wagner, Ulrich; Moch, Holger; Hillinger, Sven; Schmitt-Opitz, Isabelle; Soltermann, Alex; Wild, Peter J; Tischler, Verena (2018). Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study. Pathology, Research and Practice, 214(4):572-578.

Vital, D; Holzmann, D; Huber, G F; Moch, H; Morand, G B; Ikenberg, K (2018). PD-L1 is a positive prognostic factor in squamous cell carcinoma of the nasal vestibule. Rhinology, 56(3):182-190.

Fankhauser, Christian D; Schüffler, Peter J; Gillessen, Silke; Omlin, Aurelius; Rupp, Niels J; Rueschoff, Jan H; Hermanns, Thomas; Poyet, Cedric; Sulser, Tullio; Moch, Holger; Wild, Peter J (2018). Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer. OncoTarget, 9(12):10284-10293.

Liu, He; He, Zhaoyue; Bode, Peter; Moch, Holger; Simon, Hans-Uwe (2018). Downregulation of Autophagy-Related Proteins 1, 5, and 16 in Testicular Germ Cell Tumors Parallels Lowered LC3B and Elevated p62 Levels, Suggesting Reduced Basal Autophagy. Frontiers in Oncology, 8:366.

Visentin, Michele; Torozi, Angelo; Gai, Zhibo; Hausler, Stephanie; Li, Chao; Hiller, Christian; Schraml, Peter H; Moch, Holger; Kullak-Ublick, Gerd A (2018). Fluorocholine transport mediated by the organic cation transporter 2 (OCT2,SLC22A2): implication for imaging of kidney tumors. Drug Metabolism and Disposition, 46(8):1129-1136.

Silina, Karina; Soltermann, Alex; Movahedian Attar, Farkhondeh; Casanova, Ruben; Uckeley, Zina M; Thut, Helen; Wandres, Muriel; Isajevs, Sergejs; Cheng, Phil F; Curioni Fontecedro, Alessandra; Foukas, Periklis; Levesque, Mitchell P; Moch, Holger; Linē, Aija; van den Broek, Maries (2018). Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma. Cancer Research, 78(5):1308-1320.

Posch, Florian; Silina, Karina; Leibl, Sebastian; Mündlein, Axel; Moch, Holger; Siebenhüner, Alexander; Samaras, Panagiotis; Riedl, Jakob; Stotz, Michael; Szkandera, Joanna; Stöger, Herbert; Pichler, Martin; Stupp, Roger; van den Broek, Maries; Schraml, Peter; Gerger, Armin; Petrausch, Ulf; Winder, Thomas (2018). Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. OncoImmunology, 7(2):e1378844.

Singer, Jochen; Ruscheweyh, Hans-Joachim; Hofmann, Ariane L; Thurnherr, Thomas; Singer, Franziska; Toussaint, Nora C; Ng, Charlotte K Y; Piscuoglio, Salvatore; Beisel, Christian; Christofori, Gerhard; Dummer, Reinhard; Hall, Michael N; Krek, Wilhelm; Levesque, Mitchell; Manz, Markus G; Moch, Holger; Papassotiropoulos, Andreas; Stekhoven, Daniel J; Wild, Peter; Wüst, Thomas; Rinn, Bernd; Beerenwinkel, Niko (2018). NGS-pipe: a flexible, easily extendable, and highly configurable framework for NGS analysis. Bioinformatics, 34(1):107-108.

Gut, André; Moch, Holger; Choschzick, Matthias (2018). SOX2 Gene Amplification and Overexpression is Linked to HPV-positive Vulvar Carcinomas. International Journal of Gynecological Pathology, 37(1):68-73.

Rechsteiner, Markus; Dedes, Konstantin; Fink, Daniel; Pestalozzi, Bernhard; Sobottka, Bettina; Moch, Holger; Wild, Peter; Varga, Zsuzsanna (2018). Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features. Journal of Cancer Research and Clinical Oncology, 144(5):865-874.

2017

101. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V. – Verhandlungen. Edited by: Moch, Holger (2017). Heidelberg: Springer.

Pauli, C; Moch, H; Rubin, M A (2017). Etablierung einer Living Biobank. Der Pathologe, 38(S2):160-168.

Boege, Yannick; Malehmir, Mohsen; Healy, Marc E; Wolf, Monika Julia; Böhm, Friederike; Frick, Lukas; Maire, Renaud; Moch, Holger; Heikenwalder, Mathias; Weber, Achim; Lopes, Massimo; et al (2017). A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development. Cancer Cell, 32(3):342-359.e10.

Rupp, Niels J; Mischo, Axel; Moch, Holger (2017). Neue und vielversprechende molekulare Therapieoptionen in verschiedenen Subtypen des Nierenzellkarzinoms. Therapeutische Umschau. Revue thérapeutique, 74(4):171-179.

Janouskova, Hana; El Tekle, Geniver; Bellini, Elisa; Udeshi, Namrata D; Rinaldi, Anna; Ulbricht, Anna; Bernasocchi, Tiziano; Civenni, Gianluca; Losa, Marco; Svinkina, Tanya; Bielski, Craig M; Kryukov, Gregory V; Cascione, Luciano; Napoli, Sara; Enchev, Radoslav I; Mutch, David G; Carney, Michael E; Berchuck, Andrew; Winterhoff, Boris J N; Broaddus, Russell R; Schraml, Peter; Moch, Holger; Bertoni, Francesco; Catapano, Carlo V; Peter, Matthias; Carr, Steven A; Garraway, Levi A; Wild, Peter J; Theurillat, Jean-Philippe P (2017). Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors. Nature Medicine, 23(9):1046-1054.

Rodewald, A K; Bode, P; Cathomas, G; Moch, H (2017). Klinische Obduktionen in der Schweiz: ein Statusbericht. Der Pathologe, 38(5):416-421.

Vital, Domenic; Huber, Gerhard F; Holzmann, David; Moch, Holger; Ikenberg, Kristian (2017). The presence of aberrant p53 pattern is a negative prognostic predictor in squamous cell carcinoma of the nasal vestibule. European Archives of Oto-Rhino-Laryngology:3503-3512.

Bogowicz, Marta; Riesterer, Oliver; Ikenberg, Kristian; Stieb, Sonja; Moch, Holger; Studer, Gabriela; Guckenberger, Matthias; Tanadini-Lang, Stephanie (2017). Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma. International Journal of Radiation Oncology, Biology, Physics, 99(4):921-928.

Harlander, Sabine; Schönenberger, Désirée; Toussaint, Nora C; Prummer, Michael; Catalano, Antonella; Brandt, Laura; Moch, Holger; Wild, Peter J; Frew, Ian J (2017). Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice. Nature Medicine, 23(7):869-877.

Ciccarese, Chiara; Montironi, Rodolfo; Fiorentino, Michelangelo; Martignoni, Guido; Brunelli, Matteo; Iacovelli, Roberto; Lopez-Beltran, Antonio; Cheng, Liang; Scarpelli, Marina; Moch, Holger; Tortora, Giampaolo; Massari, Francesco (2017). Circulating Tumor cells: a reliable biomarker for prostate cancer treatment assessment? Current Drug Metabolism, 18(8):692-699.

Blanca, Ana; Cheng, Liang; Montironi, Rodolfo; Moch, Holger; Massari, Francesco; Fiorentino, Michelangelo; Raspollini, Maria Rosaria; Scarpelli, Marina; Lopez-Beltran, Antonio (2017). Mirna expression in bladder cancer and their potential role in clinical practice. Current Drug Metabolism, 18(8):712-722.

Montironi, Rodolfo; Cheng, Liang; Moch, Holger; Lopez-Beltran, Antonio; Scarpelli, Marina; Massari, Francesco; Fiorentino, Michelangelo; Ciccarese, Chiara; Koch, Michael; Kaimakliotis, Hristos Z; Wang, Lisha; Pili, Roberto; Mann, Steven A (2017). Targeting the programmed cell death-1 pathway in genitourinary tumors: current progress and future perspectives. Current Drug Metabolism, 18(8):700-711.

Giunchi, Francesca; Ciccarese, Chiara; Montironi, Rodolfo; Scarpelli, Marina; Lopez-Beltran, Antonio; Cheng, Liang; Moch, Holger; Massari, Francesco; Fiorentino, Michelangelo (2017). Urinary biomarkers for prostate cancer. Current Drug Metabolism, 18(8):723-726.

Chevrier, Stéphane; Levine, Jacob Harrison; Zanotelli, Vito Riccardo Tomaso; Silina, Karina; Schulz, Daniel; Bacac, Marina; Ries, Carola Hermine; Ailles, Laurie; Jewett, Michael Alexander Spencer; Moch, Holger; van den Broek, Maries; Beisel, Christian; Stadler, Michael Beda; Gedye, Craig; Reis, Bernhard; Pe'er, Dana; Bodenmiller, Bernd (2017). An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell, 169(4):736-749.e18.

Corrò, Claudia; Hejhal, Tomas; Poyet, Cédric; Sulser, Tullio; Hermanns, Thomas; Winder, Thomas; Prager, Gerald; Wild, Peter J; Frew, Ian; Moch, Holger; Rechsteiner, Markus (2017). Detecting circulating tumor DNA in renal cancer: An open challenge. Experimental and Molecular Pathology, 102(2):255-261.

Casanova, Ruben; Xia, Daniel; Rulle, Undīne; Nanni, Paolo; Grossmann, Jonas; Vrugt, Bart; Wettstein, Reto; Ballester, Rafael; Astolfo, Alberto; Weder, Walter; Moch, Holger; Stampanoni, Marco; Beck, Andrew H; Soltermann, Alex (2017). Morphoproteomic characterization of lung squamous cell carcinoma fragmentation, a histological marker of increased tumor invasiveness. Cancer Research, 77(10):2585-2593.

Vital, Domenic; Holzmann, David; Huber, Gerhard F; Soyka, Michael B; Moch, Holger; Zimmermann, Dieter R; Ikenberg, Kristian (2017). p16(INK4a) : A surrogate marker of high-risk human papillomavirus infection in squamous cell carcinoma of the nasal vestibule. Head and Neck, 39(7):1392-1398.

Zhong, Qing; Guo, Tiannan; Rechsteiner, Markus; Rüschoff, Jan H; Rupp, Niels; Fankhauser, Christian; Saba, Karim; Mortezavi, Ashkan; Poyet, Cédric; Hermanns, Thomas; Zhu, Yi; Moch, Holger; Aebersold, Ruedi; Wild, Peter J (2017). A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients. Scientific Data, 4:170014.

Williamson, Sean R; Gadde, Ramya; Trpkov, Kiril; Hirsch, Michelle S; Srigley, John R; Reuter, Victor E; Cheng, Liang; Priya Kunju, L; Barod, Ravi; Rogers, Craig G; Delahunt, Brett; Hes, Ondrej; Eble, John N; Zhou, Ming; McKenney, Jesse K; Martignoni, Guido; Fleming, Stewart; Grignon, David J; Moch, Holger; Gupta, Nilesh S (2017). Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists. Human Pathology, 63:150-156.

Mortezavi, Ashkan; Salemi, Souzan; Rupp, Niels J; Rüschoff, Jan Hendrik; Hermanns, Thomas; Poyet, Cedric; Randazzo, Marco; Simon, Hans-Uwe; Moch, Holger; Sulser, Tullio; Wild, Peter; Eberli, Daniel (2017). Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death. OncoTarget, 8(19):31765-31774.

Noske, Aurelia; Brandt, Simone; Valtcheva, Nadejda; Wagner, Ulrich; Zhong, Qing; Bellini, Elisa; Fink, Daniel; Obermann, Ellen C; Moch, Holger; Wild, Peter J (2017). Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer. OncoTarget, 8(9):14794-14805.

Wang, Hui; Schaefer, Thorsten; Konantz, Martina; Braun, Martin; Varga, Zsuzsanna; Paczulla, Anna M; Reich, Selina; Jacob, Francis; Perner, Sven; Moch, Holger; Fehm, Tanja; Kanz, Lothar; Schulze-Osthoff, Klaus; Lengerke, Claudia (2017). Prominent oncogenic roles of EVI1 in breast carcinoma. Cancer Research, 77(8):2148-2160.

Razafinjatovo, Caroline Fanja; Stiehl, Daniel; Deininger, Eva; Rechsteiner, Markus; Moch, Holger; Schraml, Peter (2017). VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma. OncoTarget, 8(6):10199-10212.

Valtcheva, Nadejda; Lang, Franziska M; Noske, Aurelia; Samartzis, Eleftherios P; Schmidt, Anna-Maria; Bellini, Elisa; Fink, Daniel; Moch, Holger; Rechsteiner, Markus; Dedes, Konstantin J; Wild, Peter J (2017). Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report. BMC Cancer, 17(1):1-9.

Wettstein, Marian S; Saba, Karim; Umbehr, Martin H; Murtola, Teemu J; Fankhauser, Christian D; Adank, Jean-Pascal; Hofmann, Marc; Sulser, Tullio; Hermanns, Thomas; Moch, Holger; Wild, Peter; Poyet, Cédric (2017). Prognostic role of preoperative serum lipid levels in patients undergoing radical prostatectomy for clinically localized prostate cancer. The Prostate, 77(5):549-556.

Hofmann, Ariane L; Behr, Jonas; Singer, Jochen; Kuipers, Jack; Beisel, Christian; Schraml, Peter; Moch, Holger; Beerenwinkel, Niko (2017). Detailed simulation of cancer exome sequencing data reveals differences and common limitations of variant callers. BMC Bioinformatics, 18(1):8.

Brandt, Simone; Samartzis, Eleftherios P; Zimmermann, Anne-Kathrin; Fink, Daniel; Moch, Holger; Noske, Aurelia; Dedes, Konstantin J. (2017). Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer. BMC Cancer, 17:44.

Velizheva, Nadezda P; Rechsteiner, Markus P; Wong, Christine E; Zhong, Qing; Rössle, Matthias; Bode, Beata; Moch, Holger; Soltermann, Alex; Wild, Peter J; Tischler, Verena (2017). Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung. Cancer Cytopathology, 125(1):30-40.

Widmann, Raphael; Caduff, Rosmarie; Giudici, Luca; Zhong, Qing; Vogetseder, Alexander; Arlettaz, Romaine; Frey, Bernhard; Moch, Holger; Bode, Peter K (2017). Value of postmortem studies in deceased neonatal and pediatric intensive care unit patients. Virchows Archiv, 470(2):217-223.

2016

Lukamowicz-Rajska, Magdalena; Mittmann, Christiane; Prummer, Michael; Zhong, Qing; Bedke, Jens; Hennenlotter, Jörg; Stenzl, Arnulf; Mischo, Axel; Bihr, Svenja; Schmidinger, Manuela; Vogl, Ursula; Blume, Iris; Karlo, Christoph; Schraml, Peter; Moch, Holger (2016). MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients. OncoTarget:15.

Verhandlungsband zur 100. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V. Edited by: Moch, Holger (2016). Berlin Heidelberg: Springer.

Ruf, Melanie; Moch, Holger; Schraml, Peter (2016). PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma. International Journal of Cancer, 139(2):396-403.

Gramatzki, Dorothee; Frei, Karl; Cathomas, Gieri; Moch, Holger; Weller, Michael; Mertz, Kirsten Diana (2016). Interleukin-33 in human gliomas: Expression and prognostic significance. Oncology Letters, 12(1):445-452.

Moch, H (2016). WHO-ISUP-Graduierungssystem für Nierenkarzinome. Der Pathologe, 37(4):355-360.

Sobottka, Bettina; Pestalozzi, Bernhard; Fink, Daniel; Moch, Holger; Varga, Zsuzsanna (2016). Similar lymphocytic infiltration pattern in primary breast cancer and their corresponding distant metastases. OncoImmunology, 5(6):e1153208.

Fankhauser, Christian D; Bode, Peter K; Hermanns, Thomas; Sander, Sophia; Beyer, Joerg; Sulser, Tullio; Altevogt, Peter; Moch, Holger; Tischler, Verena (2016). L1-CAM is commonly expressed in testicular germ cell tumours. Journal of Clinical Pathology, 69(5):460-462.

Humphrey, Peter A; Moch, Holger; Cubilla, Antonio L; Ulbright, Thomas M; Reuter, Victor E (2016). The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours. European Urology:1-14.

Mortezavi, Ashkan; Keller, Etienne Xavier; Poyet, Cédric; Hermanns, Thomas; Saba, Karim; Randazzo, Marco; Fankhauser, Christian Daniel; Wild, Peter J; Moch, Holger; Sulser, Tullio; Eberli, Daniel (2016). Clinical impact of prostate biopsy undergrading in an academic and community setting. World Journal of Urology, 34(10):1481-1490.

Bruder, Elisabeth; Moch, Holger (2016). Das Translokationskarzinom : ein kindlicher NIerentumor auch bei Erwachsenen. Der Pathologe, 37(2):159-165.

Bode, Peter K; Moch, Holger (2016). Nephroblastome : Praktisch immer in Studien! Der Pathologe, 37(2):166-171.

Moch, H (2016). Nierentumoren. Der Pathologe, 37(2):125-126.

Rohr, Ulrich-Peter; Binder, Carmen; Dieterle, Thomas; Giusti, Francesco; Messina, Carlo Guiseppe Mario; Toerien, Eduard; Moch, Holger; Schäfer, Hans Hendrik (2016). The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report. PLoS ONE, 11(3):e01498.

Moch, Holger (2016). WHO-Klassifikation von 2016 und erste S3-Leitlinie zum Nierenzellkarzinom. Was ist wichtig für die Praxis. Der Pathologe, 37(2):127-133.

Moch, Holger; Cubilla, Antonio L; Humphrey, Peter A; Reuter, Victor E; Ulbright, Thomas M (2016). The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. European Urology:1-13.

Rössle, Matthias; Cathomas, Gieri; Bonapace, Laura; Sachs, Melanie; Dehler, Silvia; Storz, Martina; Huber, Gerhard; Moch, Holger; Junt, Tobias; Mertz, Kirsten D (2016). Interleukin-33 expression indicates a favorable prognosis in malignant salivary gland tumors. International journal of surgical pathology, 24(5):394-400.

Weller, Michael; Nabors, Louis Burt; Gorlia, Thierry; Leske, Henning; Rushing, Elisabeth; Bady, Pierre; Hicking, Christine; Perry, James; Hong, Yong-Kil; Roth, Patrick; Wick, Wolfgang; Goodman, Simon L; Hegi, Monika E; Picard, Martin; Moch, Holger; Straub, Josef; Stupp, Roger (2016). Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome. OncoTarget, 7(12):15018-15032.

Paner, G; Amin, M B; Moch, H; Störkel, S (2016). Chromophobe renal cell carcinoma. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 27-28.

Moch, H; Bonsib, S M; Delahunt, B; Eble, J N; Egevad, L; Grignon, D J; Linehan, W M; Reuter, V E; Srigley, J R; Sulser, T; Tan, P H (2016). Clear cell renal cell carcinoma. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 18-21.

Moch, H; Amin, M B; Srigley, J R (2016). Germ cell tumours. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 75.

Delahunt, B; Cheville, J; Moch, H (2016). Haemangioblastoma. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 67.

Cubilla, A L; Amin, M B; Ayala, A; Ayala, G; Chaux, A; Corbishley, C; Dillner, J; Moch, H; Sanchez, D F; Soares, F A; Tamboli, P; Young, R H (2016). Malignant epithelial tumours of the penis. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 262-276.

Montinori, R; Cheng, L; Lopez-Beltran, A; Michal, M; Moch, H (2016). Multilocular cystic renal neoplasm of low malignant potential. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 22.

Moch, H; Cheville, J (2016). Neuroendocrine tumours. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 72-73.

Hes, O; Moch, H; Reuter, V E (2016). Oncocytoma. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 43-44.

Eble, J N; Moch, H; Amin, M B; Argani, P; Cheville, J; Delahunt, B; Martignoni, G; Srigley, J R; Tan, P H; Tickoo, S K (2016). Papillary adenoma. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 42-43.

Delahunt, B; Algabe, F; Cheville, J; Amin, M B; Argani, P; Martignoni, G; Moch, H; Srigley, J R; Tan, P H; Tickoo, S K (2016). Papillary renal cell carcinoma. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 23-25.

Velàzques, E F; Amin, M B; Cubilla, A L; Jenkins, D; Moch, H; Piris, A; Quint, W G V (2016). Precursor lesions of the penis. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 277-279.

Moch, H; Amin, M B; Argani, P; Cheville, J; Delahunt, B; Martignoni, G; Medeiros, L J; Srigley, J R; Tan, P H; Tickoo, S K (2016). Renal cell tumours. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 14-43.

Amin, M B; Moch, H; Alkan, S; Marques Maggio, E (2016). Renal haematopoietic neoplasms. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 73-75.

Nowicka, A M; Häuselmann, I; Borsig, L; Bolduan, S; Schindler, M; Schraml, P; Heikenwalder, M; Moch, H (2016). A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization. Oncogene, 35(24):3125-3138.

Schneider, Daniel; Riegman, Peter H J; Cronin, Maureen; Negrouk, Anastassia; Moch, Holger; Balling, Rudi; Penault-Llorca, Frederiques; Zatloukal, Kurt; Horgan, Denis (2016). Accelerating the Development and Validation of New Value-Based Diagnostics by Leveraging Biobanks. Public Health Genomics, 19(3):160-169.

Razafinjatovo, Caroline; Bihr, Svenja; Mischo, Axel; Vogl, Ursula; Schmidinger, Manuela; Moch, Holger; Schraml, Peter (2016). Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance. BMC Cancer, 16:638.

Gugger, Alenka; Barnhill, Raymond L; Seifert, Burkhardt; Dehler, Silvia; Moch, Holger; Lugassy, Claire; Marques-Maggio, Ewerton; Rushing, Elisabeth J; Mihic-Probst, Daniela (2016). Cutaneous melanoma with brain metastasis: Report of 193 patients with new observations. PLoS ONE, 11(5):e0156115.

Beleut, Manfred; Soeldner, Robert; Egorov, Mark; Guenther, Rolf; Dehler, Silvia; Morys-Wortmann, Corinna; Moch, Holger; Henco, Karsten; Schraml, Peter (2016). Discretization of Gene Expression Data Unmasks Molecular Subgroups Recurring in Different Human Cancer Types. PLoS ONE, 11(8):e0161514.

Montironi, Rodolfo; Santoni, Matteo; Sotte, Valeria; Cheng, Liang; Lopez-Beltran, Antonio; Massari, Francesco; Matrana, Marc R; Moch, Holger; Berardi, Rossana; Scarpelli, Marina (2016). Emerging immunotargets and immunotherapies in prostate cancer. Current Drug Targets, 17(7):777-782.

Stoehr, Christine G; Stoehr, Robert; Wenners, Antonia; Hartmann, Arndt; Bertz, Simone; Spath, Verena; Walter, Bernhard; Junker, Kerstin; Moch, Holger; Hinze, Raoul; Denzinger, Stefan; Bond, Elisabeth E; Bond, Gareth L; Bluemke, Karen; Weigelt, Katrin; Lieb, Verena; Nolte, Elke; Fornara, Paolo; Wullich, Bernd; Taubert, Helge; Wach, Sven (2016). Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients. Oncogenesis, 5(e205):1-5.

Schödel, Johannes; Grampp, Steffen; Maher, Eamonn R; Moch, Holger; Ratcliffe, Peter J; Russo, Paul; Mole, David R (2016). Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer. European Urology, 69(4):646-657.

Zhong, Qing; Rüschoff, Jan H; Guo, Tiannan; Gabrani, Maria; Schüffler, Peter J; Rechsteiner, Markus; Liu, Yansheng; Fuchs, Thomas J; Rupp, Niels J; Fankhauser, Christian; Buhmann, Joachim M; Perner, Sven; Poyet, Cédric; Blattner, Miriam; Soldini, Davide; Moch, Holger; Rubin, Mark A; Noske, Aurelia; Rüschoff, Josef; Haffner, Michael C; Jochum, Wolfram; Wild, Peter J (2016). Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity. Scientific Reports, 6:24146.

Rausch, S; Scharpf, M; Moch, H; Stenzl, A; Bedke, J (2016). Leiomyomatöses Nierenzellkarzinom Kontroverse um eine neue Tumorentität. Der Urologe. Ausg. A, 55(3):376-380.

Störkel, Stephan; Wild, Peter J; Moch, Holger (2016). Nierentumoren im Erwachsenenalter. In: Amann, Kerstin; Kain, Renate; Klöppel, Günter. Pathologie. Berlin Heidelberg: Springer, 443-485.

Rupp, Niels J; Schüffler, Peter J; Zhong, Qing; Falkner, Florian; Rechsteiner, Markus; Rüschoff, Jan H; Fankhauser, Christian; Drach, Matthias; Largo, Remo; Tremp, Mathias; Poyet, Cedric; Sulser, Tullio; Kristiansen, Glen; Moch, Holger; Buhmann, Joachim; Müntener, Michael; Wild, Peter J (2016). Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer. Journal of Pathology Informatics, 7:3.

Frauchiger, A L; Mangana, J; Rechsteiner, M; Moch, H; Seifert, Burkhardt; Braun, R; Dummer, R; Goldinger, S M (2016). Prognostic relevance of LDH and serum S-100 levels in Stage IV melanoma with known BRAF mutation status. British Journal of Dermatology, 174(4):823-830.

Mertz, Kirsten D; Mager, Lukas F; Wasmer, Marie-Hélène; Thiesler, Thore; Koelzer, Viktor H; Ruzzante, Giulia; Joller, Stefanie; Murdoch, Jenna R; Brümmendorf, Thomas; Genitsch, Vera; Lugli, Alessandro; Cathomas, Gieri; Moch, Holger; Weber, Achim; Zlobec, Inti; Junt, Tobias; Krebs, Philippe (2016). The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice. OncoImmunology, 5(1):e1062966.

Stoehr, Christine G; Walter, Bernhard; Denzinger, Stefan; Ghiorzo, Paola; Sturm, Richard A; Hinze, Raoul; Moch, Holger; Junker, Kerstin; Hartmann, Arndt; Stoehr, Robert (2016). The microphthalmia-associated transcription factor p.E318K mutation does not play a major role in sporadic renal cell tumors from caucasian patients. Pathobiology, 83(4):165-169.

WHO classification of tumours of the urinary system and male genital organs. Edited by: Moch, Holger; Humphrey, Peter A; Ulbright, Thomas M; Reuter, Victor E (2016). Lyon: International Agency for Research on Cancer (IARC).

2015

Feilchenfeldt, J; Varga, Z; Siano, M; Grabsch, H I; Held, U; Schuknecht, B; Trip, A; Hamaguchi, T; Gut, P; Balague, O; Khanfir, K; Diebold, J; Jochum, W; Shoji, H; Kushima, R; Wagner, D; Shimada, Y; Cats, A; Knuth, A; Moch, H; Aebi, S; Hofer, S (2015). Corrigendum: Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2). British Journal of Cancer, 113(12):1747.

Montironi, Rodolfo; Santoni, Matteo; Cheng, Liang; Lopez-Beltran, Antonio; Massari, Francesco; Matrana, Marc R; Moch, Holger; Scarpelli, Marina (2015). An overview of emerging immunotargets of genitourinary tumors. Current Drug Targets, 17:1.

Ruf, Melanie; Moch, Holger; Schraml, Peter (2015). Interaction of tumor cells with infiltrating lymphocytes via CD70 and CD27 in clear cell renal cell carcinoma. OncoImmunology, 4(12):e1049805.

Feilchenfeldt, J; Varga, Z; Siano, M; Grabsch, H I; Held, U; Schuknecht, B; Trip, A; Hamaguchi, T; Gut, P; Balague, O; Khanfir, K; Diebold, J; Jochum, W; Shoji, H; Kushima, R; Wagner, D; Shimada, Y; Cats, A; Knuth, A; Moch, H; Aebi, S; Hofer, S (2015). Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2). British Journal of Cancer, 113(5):716-721.

Poyet, Cédric; Buser, Lorenz; Roudnicky, Filip; Detmar, Michael; Hermanns, Thomas; Mannhard, Doris; Höhn, Andrej; Rüschoff, Jan; Zhong, Qing; Sulser, Tullio; Moch, Holger; Wild, Peter J (2015). Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer. Journal of Clinical Pathology:online.

Fankhauser, C D; Curioni-Fontecedro, A; Allmann, V; Beyer, J; Tischler, V; Sulser, T; Moch, H; Bode, P K (2015). Frequent PD-L1 expression in testicular germ cell tumors. British Journal of Cancer, 113(3):411-413.

Hofmann, Andreas; Thiesler, Thore; Gerrits, Bertran; Behnke, Silvia; Sobotzki, Nadine; Omasits, Ulrich; Bausch-Fluck, Damaris; Bock, Thomas; Aebersold, Ruedi; Moch, Holger; Tinguely, Marianne; Wollscheid, Bernd (2015). Surfaceome of classical Hodgkin and non-Hodgkin lymphoma. Proteomics. Clinical applications, 9(7-8):661-670.

Bieri, Uwe; Moch, Holger; Dehler, Silvia; Korol, Dimitri; Rohrmann, Sabine (2015). Changes in autopsy rates among cancer patients and their impact on cancer statistics from a public health point of view: a longitudinal study from 1980 to 2010 with data from Cancer Registry Zurich. Virchows Archiv, 466(6):637-643.

Winklhofer, Sebastian; Peter, Silvia; Tischler, Verena; Morsbach, Fabian; von Werdt, Moritz; Berens, Sandra; Modregger, Peter; Buser, Lorenz; Moch, Holger; Stampanoni, Marco; Thali, Michael; Alkadhi, Hatem; Stolzmann, Paul (2015). Diagnostic accuracy of quantitative and qualitative phase-contrast imaging for the ex vivo characterization of human coronary atherosclerotic plaques. Radiology, 277(1):64-72.

Fankhauser, Christian D; Sulser, Tullio; Zhong, Qing; Barghorn, André; Moch, Holger; Bode, Peter K (2015). CD10 expression in 325 testicular germ cell tumours. Journal of Clinical Pathology, 68(5):400-403.

Moch, Holger (2015). Neuroendokrine Tumoren der Niere. Der Pathologe, 36(3):278-282.

Dettmer, Matthias S; Schmitt, Anja Maria; Steinert, Hans; Capper, David; Moch, Holger; Komminoth, Paul; Perren, Aurel (2015). Tall cell Papillary Thyroid Carcinoma: new diagnostic criteria and mutations in BRAF and TERT. Endocrine-Related Cancer, 22(3):419-429.

Fluri, Felix; Grünstein, Dan; Cam, Ertugrul; Ungethuem, Udo; Hatz, Florian; Schäfer, Juliane; Samnick, Samuel; Israel, Ina; Kleinschnitz, Christoph; Orts-Gil, Guillermo; Moch, Holger; Zeis, Thomas; Schaeren-Wiemers, Nicole; Seeberger, Peter (2015). Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats. Experimental Neurology, 265:142-151.

Ruf, Melanie; Mittmann, Christiane; Nowicka, Anna M; Hartmann, Arndt; Hermanns, Thomas; Poyet, Cédric; van den Broek, Maries; Sulser, Tullio; Moch, Holger; Schraml, Peter (2015). pVHL/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma. Clinical Cancer Research, 21(4):889-98.

Frischknecht, Lukas; Meerang, Mayura; Soltermann, Alex; Stahel, Rolf; Moch, Holger; Seifert, Burkhardt; Weder, Walter; Opitz, Isabelle (2015). Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery. Journal of Thoracic and Cardiovascular Surgery, 149(6):1539-1547.e1.

Shakhova, Olga; Cheng, Phil; Mishra, Pravin J; Zingg, Daniel; Schaefer, Simon M; Debbache, Julien; Häusel, Jessica; Matter, Claudia; Guo, Theresa; Davis, Sean; Meltzer, Paul; Mihic-Probst, Daniela; Moch, Holger; Wegner, Michael; Merlino, Glenn; Levesque, Mitchell P; Dummer, Reinhard; Santoro, Raffaella; Cinelli, Paolo; Sommer, Lukas (2015). Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma. PLoS Genetics, 11(1):e1004877.

Frew, Ian J; Moch, Holger (2015). A clearer view of the molecular complexity of clear cell renal cell carcinoma. Annual Review of Pathology, 10(1):263-289.

Rechsteiner, M; Wild, P; Kiessling, M K; Bohnert, A; Zhong, Q; Stahel, R A; Moch, H; Curioni-Fontecedro, A (2015). A novel germline mutation of PDGFR-β might be associated with clinical response of colorectal cancer to regorafenib. Annals of Oncology, 26(1):246-248.

Mangana, Joanna; Cheng, Phil F; Schindler, Katja; Weide, Benjamin; Held, Ulrike; Frauchiger, Anna L; Romano, Emanuella; Kähler, Katharina C; Rozati, Sima; Rechsteiner, Markus; Moch, Holger; Michielin, Olivier; Garbe, Claus; Hauschild, Axel; Hoeller, Christoph; Dummer, Reinhard; Goldinger, Simone M (2015). Analysis of BRAF and NRAS mutation status in advanced melanoma patients treated with anti-CTLA-4 antibodies: association with overall survival? PLoS ONE, 10(10):e0139438.

Lopez-Beltran, Antonio; Santoni, Matteo; Massari, Francesco; Ciccarese, Chiara; Tortora, Giampaolo; Cheng, Liang; Moch, Holger; Scarpelli, Marina; Reymundo, Carlos; Montironi, Rodolfo (2015). Bladder cancer: molecular determinants of personalized therapy. Current Drug Targets, 16(2):115-124.

Curioni-Fontecedro, Alessandra; Martin, Vittoria; Vogetseder, Alexander; Knuth, Alexander; Moch, Holger; Soldini, Davide; Tinguely, Marianne (2015). Chromosomal aberrations of cancer-testis antigens in myeloma patients. Hematological oncology, 33(3):159-163.

Huber, F; Montani, M; Sulser, T; Jaggi, R; Wild, P; Moch, H; Gevensleben, H; Schmid, M; Wyder, S; Kristiansen, G (2015). Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer-what has gone wrong? A blueprint for the way forward in biomarker studies. British Journal of Cancer, 112:140-148.

Pflueger, Dorothee; Mittmann, Christiane; Dehler, Silvia; Rubin, Mark A; Moch, Holger; Schraml, Peter (2015). Functional characterization of BC039389-GATM and KLK4-KRSP1 chimeric read-through transcripts which are up-regulated in renal cell cancer. BMC Genomics, 16(247):online.

Eppler, Elisabeth; Janas, Eva; Link, Karl; Weidmann, Lukas; Bischofberger, Helena; Wenger, Michael; Tinguely, Marianne; Schraml, Peter; Moch, Holger; Fellbaum, Christian (2015). Insulin-like growth factor I is expressed in classical and nodular lymphocyte-predominant Hodgkin's lymphoma tumour and microenvironmental cells. Cell and Tissue Research, 359(3):841-851.

Friemel, Juliane; Rechsteiner, Markus Peter; Frick, Lukas; Boehm, Friederike; Struckmann, Kirsten; Sigg, Michele; Moch, Holger; Heikenwaelder, Mathias; Weber, Achim (2015). Intratumor heterogeneity in hepatocellular carcinoma. Clinical Cancer Research, 21(8):1951-1961.

Curioni-Fontecedro, A; Pitocco, R; Schoenewolf, N L; Holzmann, D; Soldini, D; Dummer, R; Calvieri, S; Moch, H; Mihic-Probst, D; Fitsche, A (2015). Intratumoral heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 expression in mucosal melanoma. BioMed Research International, 2015:432479.

Mosquera, Juan-Miguel; Varma, Sonal; Pauli, Chantal; MacDonald, Theresa Y; Yashinskie, Jossie J; Varga, Zsuzsanna; Sboner, Andrea; Moch, Holger; Rubin, Mark A; Shin, Sandra J (2015). MAGI3–AKT3 fusion in breast cancer amended. Nature, 520(7547):E11-E12.

Fisher, Kurt W; Montironi, Rodolfo; Lopez Beltran, Antonio; Moch, Holger; Wang, Lisha; Scarpelli, Marina; Williamson, Sean R; Koch, Michael O; Cheng, Liang (2015). Molecular foundations for personalized therapy in prostate cancer. Current Drug Targets, 16(2):103-114.

Moch, Holger; Montironi, Rodolfo; Lopez-Beltran, Antonio; Cheng, Liang; Mischo, Axel (2015). Oncotargets in different renal cancer subtypes. Current Drug Targets, 16(2):125-135.

2014

Noske, Aurelia; Henricksen, Leigh A; LaFleur, Bonnie; Zimmermann, Anne-Katrin; Tubbs, Alisa; Singh, Shalini; Storz, Martina; Fink, Daniel; Moch, Holger (2014). Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes. Experimental and Molecular Pathology, 98(1):47-54.

Montironi, Rodolfo; Santoni, Matteo; Lopez-Beltran, Antonio; Cheng, Liang; Moch, Holger; Scarpelli, Marina (2014). Morphologic and molecular backgrounds for personalized management of genito-urinary cancers: an Overview. Current Drug Targets, 16(2):96-102.

Rioux-Leclercq, Nathalie; Ferran, Algaba; Mahul, Amin; Argani, Pedram; Billis, Athanase; Bonsib, Stephen; Cheng, Liang; Cheville, John; Eble, John; Egevad, Lars; Epstein, Jonathan; Grignon, David; Hes, Ondrej; Humphrey, Peter; Magi-Galluzzi, Cristina; Martignoni, Guido; McKenney, Jesse; Merino, Maria; Moch, Holger; Montironi, Rodolfo; Netto, George; Reuter, Viktor; Samaratunga, Hemamali; Shen, Steven; Srigley, John; Tamboli, Pheroze; Tan, Puay Hoon; Tickoo, Satish; Trpkov, Kiril; Zhou, Ming; Delahunt, Brett; Comperat, Eva (2014). Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations. Annales de Pathologie, 34(6):448-461.

Walter, Katharina M; Schönenberger, Miriam J; Trötzmüller, Martin; Horn, Michael; Elsässer, Hans-Peter; Moser, Ann B; Lucas, Miriam S; Schwarz, Tobias; Gerber, Philipp A; Faust, Phyllis L; Moch, Holger; Köfeler, Harald C; Krek, Wilhelm; Kovacs, Werner J (2014). Hif-2α promotes degradation of Mammalian peroxisomes by selective autophagy. Cell Metabolism, 20(5):882-897.

Wang, Yihua; Bu, Fangfang; Royer, Christophe; Serres, Sébastien; Larkin, James R; Soto, Manuel Sarmiento; Sibson, Nicola R; Salter, Victoria; Fritzsche, Florian; Turnquist, Casmir; Koch, Sofia; Zak, Jaroslav; Zhong, Shan; Wu, Guobin; Liang, Anmin; Olofsen, Patricia A; Moch, Holger; Hancock, David C; Downward, Julian; Goldin, Robert D; Zhao, Jian; Tong, Xin; Guo, Yajun; Lu, Xin (2014). ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1. Nature Cell Biology, 16(11):1092-1104.

Fellmann, Jonas; Weisert, Jan U; Soltermann, Alex; Morand, Grégoire; Morra, Laura; Moch, Holger; Huber, Gerhard F; Probst, Rudolf (2014). Helicobacter pylori detected in pharyngeal and laryngeal pathologies in patients with proven gastric colonization. Head and Neck, 36(11):1562-1566.

von Laffert, Maximilian; Warth, Arne; Penzel, Roland; Schirmacher, Peter; Kerr, Keith M; Elmberger, Göran; Schildhaus, Hans-Ulrich; Büttner, Reinhard; Lopez-Rios, Fernando; Reu, Simone; Kirchner, Thomas; Pauwels, Patrick; Specht, Katja; Drecoll, Enken; Höfler, Heinz; Aust, Daniela; Baretton, Gustavo; Bubendorf, Lukas; Stallmann, Sonja; Fisseler-Eckhoff, Annette; Soltermann, Alex; Tischler, Verena; Moch, Holger; Penault-Llorca, Frederique; Hager, Hendrik; Schäper, Frank; Lenze, Dido; Hummel, Michael; Dietel, Manfred (2014). Multicenter Immunohistochemical ALK-Testing of Non-Small-Cell Lung Cancer Shows High Concordance after Harmonization of Techniques and Interpretation Criteria. Journal of Thoracic Oncology, 9(11):1685-1692.

Meller, Sebastian; Bicker, Anne; Montani, Matteo; Ikenberg, Kristian; Rostamzadeh, Babak; Sailer, Verena; Wild, Peter; Dietrich, Dimo; Uhl, Barbara; Sulser, Tullio; Moch, Holger; Gorr, Thomas A; Stephan, Carsten; Jung, Klaus; Hankeln, Thomas; Kristiansen, Glen (2014). Myoglobin expression in prostate cancer is correlated to androgen receptor expression and markers of tumor hypoxia. Virchows Archiv, 465(4):419-427.

Curioni-Fontecedro, A; Soldini, D; Seifert, B; Eichmueller, T; Korol, D; Moch, H; Weder, W; Stahel, R (2014). A Comprehensive Analysis of Markers for Neuroendocrine Tumors of the Lungs Demonstrates Estrogen Receptor Beta to be a Prognostic Markers in SCLC Male Patients. Journal of Cytology & Histology:5:268.

Ikenberg, Kristian; Valtcheva, Nadejda; Brandt, Simone; Zhong, Qing; Wong, Christine E; Noske, Aurelia; Rechsteiner, Markus; Rueschoff, Jan H; Caduff, Rosmarie; Dellas, Athanassios; Obermann, Ellen; Fink, Daniel; Fuchs, Thomas; Krek, Wilhelm; Moch, Holger; Frew, Ian J; Wild, Peter J (2014). KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. Journal of Pathology, 234(2):239-252.

Dettmer, Matthias S; Perren, Aurel; Moch, Holger; Komminoth, Paul; Nikiforov, Yuri E; Nikiforova, Marina N (2014). MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights. Journal of Molecular Endocrinology, 52(2):181-189.

Bitanihirwe, Byron K Y; Meerang, Mayura; Friess, Martina; Soltermann, Alex; Frischknecht, Lukas; Thies, Svenja; Felley-Bosco, Emanuela; Tsao, Ming-Sound; Allo, Ghassan; de Perrot, Marc; Seifert, Burkhardt; Moch, Holger; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2014). PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy. Journal of Thoracic Oncology, 9(2):239-247.

98. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V. Edited by: Moch, Holger (2014). Berlin Heidelberg: Springer.

Lenggenhager, Daniela; Curioni-Fontecedro, Alessandra; Storz, Martina; Shakhova, Olga; Sommer, Lukas; Widmer, Daniel S; Seifert, Burkhardt; Moch, Holger; Dummer, Reinhard; Mihic-Probst, Daniela (2014). An aggressive hypoxia related subpopulation of melanoma cells is TRP-2 Negative. Translational Oncology, 7(2):206-212.

Rechsteiner, Markus P; Floros, Xenofon; Boehm, Bernhard O; Marselli, Lorella; Marchetti, Piero; Stoffel, Markus; Moch, Holger; Spinas, Giatgen A (2014). Automated assessment of β-cell area and density per islet and patient using TMEM27 and BACE2 immunofluorescence staining in human pancreatic β-cells. PLoS ONE, 9(6):e98932.

Moch, Holger; Srigley, John; Delahunt, Brett; Montironi, Rodolfo; Egevad, Lars; Tan, Puay Hoon (2014). Biomarkers in renal cancer. Virchows Archiv, 464(3):359-365.

Wyler, L; Napoli, C U; Ingold, B; Sulser, T; Heikenwälder, M; Schraml, P; Moch, H (2014). Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression. British Journal of Cancer, 110(3):686-694.

Bode, Peter K; Thielken, Andrea; Brandt, Simone; Barghorn, André; Lohe, Bernd; Knuth, Alexander; Moch, Holger (2014). Cancer testis antigen expression in testicular germ cell tumorigenesis. Modern Pathology, 27(6):899-905.

Amin, Mahul B; Smith, Steven C; Agaimy, Abbas; Argani, Pedram; Compérat, Eva Marie; Delahunt, Brett; Epstein, Jonathan I; Eble, John N; Grignon, David J; Hartmann, Arndt; Hes, Ondřej; Hirsch, Michelle S; Jimenez, Rafael E; Kunju, Lakshmi P; Martignoni, Guido; McKenney, Jesse K; Moch, Holger; Montironi, Rodolfo; Paner, Gladell P; Rao, Priya; Srigley, John R; Tickoo, Satish K; Reuter, Victor E (2014). Collecting duct carcinoma versus renal medullary carcinoma: An appeal for nosologic and biological clarity. American Journal of Surgical Pathology, 38(7):871-874.

Varga, Zsuzsanna; Tubbs, Raymond R; Moch, Holger (2014). Concomitant Detection of HER2 Protein and Gene Alterations by Immunohistochemistry (IHC) and Silver Enhanced In Situ Hybridization (SISH) Identifies HER2 Positive Breast Cancer with and without Gene Amplification. PLoS ONE, 9(8):e105961.

Berens, S; Vogt, P; Alkadhi, H; Berger, N; Moch, H (2014). Das schilddrüsenähnliche follikuläre Nierenzellkarzinom. Der Pathologe, 35(1):83-87.

Koppensteiner, Romana; Samartzis, Eleftherios P; Noske, Aurelia; von Teichman, Adriana; Dedes, Ioannis; Gwerder, Myriam; Imesch, Patrick; Ikenberg, Kristian; Moch, Holger; Fink, Daniel; Stucki, Manuel; Dedes, Konstantin J (2014). Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro. PLoS ONE, 9(6):e100041.

Poyet, Cédric; Jentsch, Bastian; Hermanns, Thomas; Schweckendiek, Daniel; Seifert, Hans-Helge; Schmidtpeter, Martin; Sulser, Tullio; Moch, Holger; Wild, Peter J; Kristiansen, Glen (2014). Expression of histone deacetylases 1,2 and 3 in urothelial bladder cancer. BMC Clinical Pathology, 14:10.

Moch, Holger (2014). Kidney Cancer. In: Stewart, B W; Wild, C P. World Cancer report 2014. Lyon: IARC, 2-9.

Bode, Peter K; Cathomas, Gieri; Vogt, Peter; Moch, Holger (2014). Klinische Autopsie. Praxis, 103(2):65-71.

Wolf, Monika Julia; Adili, Arlind; Piotrowitz, Kira; et al; Boege, Yannick; Egger, Michèle; Moch, Holger; Kopf, Manfred; Weber, Achim; Heikenwalder, Mathias (2014). Metabolic activation of intrahepatic CD8(+) T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell, 26(4):549-564.

Rechsteiner, Markus; Müller, Rouven; Reineke, Tanja; Goede, Jeroen; Bohnert, Annette; Zhong, Qing; Manz, Markus G; Moch, Holger; Wild, Peter J; Zimmermann, Dieter R; Tinguely, Marianne (2014). Modelling of a genetically diverse evolution of Systemic Mastocytosis with Chronic Myelomonocytic Leukemia (SM-CMML) by next generation sequencing. Experimental Hematology & Oncology, 3:18.

Theurillat, Jean-Philippe P; Udeshi, Namrata D; Errington, Wesley J; et al; Wild, Peter J; Moch, Holger; Garraway, Levi A (2014). Prostate cancer: Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer. Science, 346(6205):85-89.

Blattner, Mirjam; Lee, Daniel J; O'Reilly, Catherine; Park, Kyung; MacDonald, Theresa Y; Khani, Francesca; Turner, Kevin R; Chiu, Ya-Lin; Wild, Peter J; Dolgalev, Igor; Heguy, Adriana; Sboner, Andrea; Ramazangolu, Sinan; Hieronymus, Haley; Sawyers, Charles; Tewari, Ashutosh K; Moch, Holger; Yoon, Ghil Suk; Known, Yong Chul; Andrén, Ove; Fall, Katja; Demichelis, Francecsa; Mosquera, Juan Miguel; Robinson, Brian D; Barbieri, Christopher E; Rubin, Mark A (2014). SPOP mutations in prostate cancer across demographically diverse patient cohorts. Neoplasia, 16(1):14-20.

Bode, P K; Moch, H (2014). Seminome des Hodens : Klassisch und weniger klassisch. Der Pathologe, 35(3):224-231.

Rauch, P J; Müllhaupt, B; Biedermann, L; Manz, M G; Ruschitzka, F; Flammer, A; Segerer, S T; Mohebbi, N; Jung, H H; Moch, H; Ikenberg, K; Aguzzi, A; Nuvolone, M; Distler, O; Rauch, A; Fehr, T H; Gerber, B (2014). Systemische Amyloidosen. Swiss Medical Forum, 14(50):943-948.

Moch, Holger; Lukamowicz-Rajska, Magdalena (2014). miR-30c-2-3p and miR-30a-3p: New pieces of the Jigsaw puzzle in HIF2α regulation. Cancer Discovery, 4(1):22-24.

2013

97. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V. Edited by: Moch, Holger (2013). Berlin Heidelberg: Springer.

Tordella, L; Koch, S; Salter, V; Pagotto, A; Doondeea, J B; Feller, S M; Ratnayaka, I; Zhong, S; Goldin, R D; Lozano, G; McKeon, F D; Tavassoli, M; Fritzsche, F; Huber, G F; Rössle, M; Moch, H; Lu, X (2013). ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63. Proceedings of the National Academy of Sciences of the United States of America, 110(44):17969-17974.

Varga, Zsuzsanna; Noske, Aurelia; Ramach, Constanze; Padberg, Barbara; Moch, Holger (2013). Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control study. BMC Cancer, 13:615.

Autopsie und Religion: Die Sektion aus medizinischer, ethischer und religiöser Sicht. Edited by: Tag, Brigitte; Mausbach, Julian; Moch, Holger (2013). Weimar: VDG Verlag und Datenbank für Geisteswissenschaften.

Albers, Joachim; Rajski, Michal; Schönenberger, Désirée; Harlander, Sabine; Schraml, Peter; von Teichman, Adriana; Georgiev, Strahil; Wild, Peter J; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2013). Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice. EMBO Molecular Medicine, 5(6):949-964.

Varga, Zsuzsanna; Sinn, Peter; Fritzsche, Florian; von Hochstetter, Arthur; Noske, Aurelia; Schraml, Peter; Tausch, Christoph; Trojan, Andreas; Moch, Holger (2013). Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer. PLoS ONE, 8(3):e58483.

Dettmer, Matthias Stephan; Perren, Aurel; Moch, Holger; Komminoth, Paul; Nikiforov, Yuri E; Nikiforova, Marina N (2013). Comprehensive microRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma. Thyroid, 23(11):1383-1389.

Reiner, Caecilia S; Roessle, Matthias; Thiesler, Thore; Eberli, Daniel; Klotz, Ernst; Frauenfelder, Thomas; Sulser, Tullio; Moch, Holger; Alkadhi, Hatem (2013). Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers. Investigative Radiology, 48(4):183-191.

Varga, Zsuzsanna; Sinn, Peter; Fritzsche, Florian; von Hochstetter, Arthur; Noske, Aurelia; Schraml, Peter; Tausch, Christoph; Trojan, Andreas; Moch, Holger (2013). Correction: Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer. PLoS ONE, 8(10):online.

Boos, Laura A; Dettmer, Matthias; Schmitt, Anja; Rudolph, Thomas; Steinert, Hans; Moch, Holger; Sobrinho-Simões, Manuel; Komminoth, Paul; Perren, Aurel (2013). Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases. Histopathology, 63(2):234-241.

Rössle, M; Weber, C S; Züllig, L; Graf, N; Jochum, W; Stöckli, S J; Moch, H; Huber, G F (2013). EGFR expression and copy number changes in low T-stage oral squamous cell carcinomas. Histopathology, 63(2):271-278.

Eichelberg, Christian; Chun, Felix K; Bedke, Jens; Heuer, Roman; Adam, Meike; Moch, Holger; Terracciano, Luigi; Hinrichs, Kristin; Dahlem, Roland; Fisch, Margit; Schlomm, Thorsten; Sauter, Guido; Minner, Sarah (2013). Epithelial cell adhesion molecule (EPCAM) is an independent prognostic marker in clear cell renal carcinoma. International journal of cancer. Journal international du cancer, 132(12):2948-2955.

Sanjmyatav, Jimsgene; Hauke, Sven; Gajda, Mieczyslaw; Hartmann, Arndt; Moch, Holger; Meyer, Britta; Pryalukhin, Alexey; Grimm, Marc-Oliver; Junker, Kerstin (2013). Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. European Urology, 64(4):689-691.

Zimmermann, Anne-Katrin; Imig, Jochen; Klar, Agnes; Renner, Christoph; Korol, Dimitri; Fink, Daniel; Stadlmann, Sylvia; Singer, Gad; Knuth, Alexander; Moch, Holger; Caduff, Rosmarie (2013). Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas. Virchows Archiv, 462(5):565-574.

Lenggenhager, Daniela; Maggio, Ewerton M; Moch, Holger; Rössle, Matthias (2013). HBME-1 expression in hyalinizing trabecular tumours of the thyroid gland. Histopathology, 62(7):1092-1097.

Züllig, L; Roessle, M; Weber, C; Graf, N; Haerle, S K; Jochum, W; Stoeckli, S J; Moch, H; Huber, G F (2013). High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity. European Journal of Cancer, 49(8):1915-1922.

Pflueger, Dorothee; Sboner, Andrea; Storz, Martina; Roth, Jasmine; Compérat, Eva; Bruder, Elisabeth; Rubin, Mark A; Schraml, Peter; Moch, Holger (2013). Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing. Neoplasia, 15(11):1231-1240.

Broglie, M A; Soltermann, A; Rohrbach, D; Haile, S R; Pawlita, M; Studer, G; Huber, G F; Moch, H; Stoeckli, S J (2013). Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation. Head and Neck, 35(12):1698-1706.

Roth, P; Silginer, M; Goodman, S L; Hasenbach, K; Thies, S; Maurer, G; Schraml, P; Tabatabai, G; Moch, H; Tritschler, I; Weller, M (2013). Integrin control of the transforming growth factor-β pathway in glioblastoma. Brain, 136(2):564-576.

Hell, Michael P; Duda, Maria; Weber, Thomas C; Moch, Holger; Krek, Wilhelm (2013). Ischemic renal injury reveals in vivo functions for the von Hippel-Lindau tumor suppressor in mitotic fidelity control. Cancer Research:1-32.

Rechsteiner, Markus; von Teichman, Adriana; Rüschoff, Jan H; Fankhauser, Niklaus; Pestalozzi, Bernhard; Schraml, Peter; Weber, Achim; Wild, Peter; Zimmermann, Dieter; Moch, Holger (2013). KRAS, BRAF, and TP53 deep-sequencing for colorectal carcinoma patient diagnostics. Journal of Molecular Diagnostics, 15(3):299-311.

Moch, Holger (2013). Klassifikation und molekulare Veränderungen des Nierenzellkarzinoms. Schweizer Zeitschrift für Onkologie, (3):5-9.

Pawłowski, Rafal; Mühl, Sarah M; Sulser, Tullio; Krek, Wilhelm; Moch, Holger; Schraml, Peter (2013). Loss of PBRM1 expression is associated with renal cell carcinoma progression. International Journal of Cancer, 132(2):E11-7.

Perner, Sven; Rupp, Niels J; Braun, Martin; Rubin, Mark A; Moch, Holger; Dietel, Manfred; Wernert, Nicolas; Jung, Klaus; Stephan, Carsten; Kristiansen, Glen (2013). Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course. International Journal of Cancer, 132(4):807-812.

Dettmer, Matthias; Vogetseder, Alexander; Durso, Mary Beth; Moch, Holger; Komminoth, Paul; Perren, Aurel; Nikiforov, Yuri E; Nikiforova, Marina N (2013). MicroRNA Expression Array Identifies Novel Diagnostic Markers for Conventional and Oncocytic Follicular Thyroid Carcinomas. The Journal of clinical endocrinology and metabolism, 98(1):E1-7.

von Boehmer, Lotta; Mattle, Muriel; Bode, Peter; Landshammer, Alexandro; Schäfer, Carolin; Nuber, Natko; Ritter, Gerd; Old, Lloyd; Moch, Holger; Schäfer, Niklaus; Jäger, Elke; Knuth, Alexander; van den Broek, Maries (2013). NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma. Cancer Immunity, 13:12.

Blyszczuk, Przemyslaw; Berthonneche, Corrine; Behnke, Silvia; Glönkler, Marcel; Moch, Holger; Pedrazzini, Thierry; Lüscher, Thomas F; Eriksson, Urs; Kania, Gabriela (2013). Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatory CD133+ progenitors into F4/80+ macrophages in experimental autoimmune myocarditis. Cardiovascular Research, 97(2):219-229.

Wild, Peter J; Zhong, Qing; Zimmermann, Dieter R; Rechsteiner, Markus; Fritz, Christine; Valtcheva, Nadejda; Moch, Holger (2013). Personalisierte Krebsmedizin und die Zukunft der Pathologie. info@onkologie, 6:9-12.

Eichelberg, C; Minner, S; Isbarn, H; Burandt, E; Terracciano, L; Moch, H; Kell, A; Heuer, R; Chun, F K; Sauter, G; Fisch, M; Tennstedt, P (2013). Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma. World Journal of Urology, 31(4):847-853.

Braun, Martin; Kirsten, Robert; Rupp, Niels J; Moch, Holger; Fend, Falko; Wernert, Nicolas; Kristiansen, Glen; Perner, Sven (2013). Quantification of protein expression in cells and cellular subcompartments on immunohistochemical sections using a computer supported image analysis system. Histology and Histopathology, 28(5):605-610.

Sharma, Anu; Bode, Beata; Moch, Holger; Okoniewski, Michal; Knuth, Alexander; von Boehmer, Lotta; van den Broek, Maries (2013). Radiotherapy of human sarcoma promotes an intratumoral immune effector signature. Clinical Cancer Research, 19(17):4843-4853.

Tan, Puay Hoon; Cheng, Liang; Rioux-Leclercq, Nathalie; Merino, Maria J; Netto, George; Reuter, Victor E; Shen, Steven S; Grignon, David J; Montironi, Rodolfo; Egevad, Lars; Srigley, John R; Delahunt, Brett; Moch, Holger (2013). Renal tumors: Diagnostic and prognostic biomarkers. American Journal of Surgical Pathology, 37(10):1518-1531.

Sanjmyatav, Jimsgene; Hartmann, Arndt; Moch, Holger; Hauke, Sven; Gajda, Mieczyslaw; Meyer, Britta; Pryalukhin, Alexey; Grimm, Marc-Oliver; Junker, Kerstin (2013). Reply to Jérôme Verine, Christophe Leboeuf and Philippe Ratajczak's Letter to the Editor re: Jimsgene Sanjmyatav, Sven Hauke, Mieczyslaw Gajda, et al. Establishment of a Multicolour Fluorescence In Situ Hybridisation-based Assay for Subtyping of Renal Cell Tumours. Eur Urol 2013;64:689-91. European Urology:1.

Zeh, Nina; Wild, Peter J; Bode, Peter K; Kristiansen, Glen; Moch, Holger; Sulser, Tullio; Hermanns, Thomas (2013). Retroperitoneal teratoma with somatic malignant transformation: A papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy. BMC Urology, 13:9.

Deisl, Christine; Simonin, Alexandre; Anderegg, Manuel; Albano, Giuseppe; Kovacs, Gergely; Ackermann, Daniel; Moch, Holger; Dolci, Wanda; Thorens, Bernard; Hediger, Matthias A; Fuster, Daniel G (2013). Sodium/hydrogen exchanger NHA2 is critical for insulin secretion in β-cells. Proceedings of the National Academy of Sciences of the United States of America, 110(24):10004-10009.

Dannenmann, Stefanie R; Hermanns, Thomas; Bransi, Ali; Matter, Claudia; von Boehmer, Lotta; Stevanovic, Stefan; Schraml, Peter; Moch, Holger; Knuth, Alexander; van den Broek, Maries (2013). Spontaneous peripheral T-cell responses toward the tumor-associated antigen cyclin D1 in patients with clear cell renal cell carcinoma. Cancer Immunology Research, 1(5):288-295.

Tag, Brigitte; Moch, Holger (2013). Symposium Autopsie und Religion. In: Hacker, Jörg. Jahrbuch 2012. Leopoldina (R. 3). Stuttgart: Deutsche Akademie der Naturforscher Leopoldina, 414-422.

Rechsteiner, Markus; Zimmermann, Anne-Katrin; Wild, Peter J; Caduff, Rosmarie; von Teichman, Adriana; Fink, Daniel; Moch, Holger; Noske, Aurelia (2013). TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type. Experimental and Molecular Pathology, 95(2):235-241.

Srigley, John R; Delahunt, Brett; Eble, John N; Egevad, Lars; Epstein, Jonathan I; Grignon, David; Hes, Ondrej; Moch, Holger; Montironi, Rodolfo; Tickoo, Satish K; Zhou, Ming; Argani, Pedram (2013). The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. American Journal of Surgical Pathology, 37(10):1469-1489.

Delahunt, Brett; Cheville, John C; Martignoni, Guido; Humphrey, Peter A; Magi-Galluzzi, Cristina; McKenney, Jesse; Egevad, Lars; Algaba, Ferran; Moch, Holger; Grignon, David J; Montironi, Rodolfo; Srigley, John R (2013). The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. American Journal of Surgical Pathology, 37(10):1490-1504.

Casagrande, Silvia; Ruf, Melanie; Rechsteiner, Markus; Morra, Laura; Brun-Schmid, Sonja; von Teichman, Adriana; Krek, Wilhelm; Schraml, Peter; Moch, Holger (2013). The Protein-Tyrosine Phosphatase Receptor Type J is regulated by the pVHL-HIF axis in Clear Cell Renal Cell Carcinoma. Journal of Pathology, 229(4):525-534.

Teleki, Ivett; Krenacs, Tibor; Szasz, Marcell A; Kulka, Janina; Wichmann, Barna; Leo, Cornelia; Papassotiropoulos, Barbel; Riemenschnitter, Cosima; Moch, Holger; Varga, Zsuzsanna (2013). The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer. BMC Cancer, 13(1):50.

Tag, Brigitte; Mausbach, Julian; Moch, Holger (2013). Thematische Einführung. In: Tag, Brigitte; et al. Autopsie und Religion: Die Sektion aus medizinischer, ethischer und religiöser Sicht. Weimar: VDG - Verlag und Datenbank fuer Geisteswissenschaften, 9-13.

Storz, Martina; Moch, Holger (2013). Tissue microarrays and biomarker validation in molecular diagnostics. In: Cheng, Liang; Zhang, David Y; Eble, John N. Molecular Genetic Pathology. New York: Springer, 455-461.

Dannenmann, Stefanie Regine; Thielicke, Julia; Stöckli, Martina; Matter, Claudia; von Boehmer, Lotta; Cecconi, Virginia; Hermanns, Thomas; Hefermehl, Lukas; Schraml, Peter; Moch, Holger; Knuth, Alexander; van den Broek, Maries (2013). Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma. OncoImmunology, 2(3):e23562.

Rössle, Matthias; Sigg, Michèle; Rüschoff, Jan H; Wild, Peter J; Moch, Holger; Weber, Achim; Rechsteiner, Markus P (2013). Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF (V600E) mutations in colorectal carcinoma. Virchows Archiv, 463(5):623-631.

Moch, Holger; Rössle, Matthias (2013). Von der personalisierten Diagnostik zur individualisierten Therapie. In: Marti, Rolf. Krebsforschung in der Schweiz. Bern: Krebsliga Schweiz, 61-64.

Vogetseder, A; Thies, S; Ingold, B; Roth, P; Weller, M; Schraml, P; Goodman, S L; Moch, H (2013). αv-Integrin isoform expression in primary human tumors and brain metastases. International Journal of Cancer, 133(10):2362-2371.

2012

Rössle, M; Moch, H (2012). Bedeutung molekularpathologischer Methoden in der Onkologie. Der Onkologe, 18(12):1149-1156.

Der Pathologe : Verhandlungen 2012 der Deutschen Gesellschaft für Pathologie e.V. Edited by: Moch, Holger (2012). Berlin: Springer-Verlag.

Moch, H; Kerjaschki, D; Kain, R; Ammann, K (2012). Niere. In: Böcker, W; Denk, H; Heitz, P U; Moch, H; Höfler, G; Kreipe, H. Pathologie. München: Urban & Fischer, Elsevier, 693-720.

Pathologie. Edited by: Böcker, Werner; Denk, Helmut; Heitz, Philipp; Moch, Holger; Höfler, Gerald; Kreipe, Hans (2012). München: Elsevier.

Moch, Holger; Zimmermann, Dieter R; Probst-Hensch, Nicole (2012). Pathologie: Aufgaben und Methoden. In: Böcker, W; Denk, H; Heitz, P U; Höfler, G; Kreipe, H; Moch, H. Pathologie. München: Elsevier, Urban & Fischer, 3-19.

Moch, H; Höfler, H K; Lax, S; Moll, R; Tannapfel, A; Zimmermann, D R (2012). Tumorerkrankungen. In: Böcker, W; Denk, H; Heitz, P U; Höfler, G; Kreipe, H; Moch, H. Pathologie. München: Elsevier, Urban & Fischer, 123-169.

Boysen, Gunther; Bausch-Fluck, Damaris; Thoma, Claudio R; Nowicka, Anna M; Stiehl, Daniel P; Cima, Igor; Van-Duc, Luu; von Teichman, Adriana; Hermanns, Thomas; Sulser, Tullio; Ingold-Heppner, Barbara; Fankhauser, Niklaus; Wenger, Roland H; Krek, Wilhelm; Schraml, Peter; Wollscheid, Bernd; Moch, Holger (2012). Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma. Neoplasia, 14(6):535-546.

Meyer, Stefanie; Fuchs, Thomas J; Bosserhoff, Anja K; Hofstädter, Ferdinand; Pauer, Armin; Roth, Volker; Buhmann, Joachim M; Moll, Ingrid; Anagnostou, Nikos; Brandner, Johanna M; Ikenberg, Kristian; Moch, Holger; Landthaler, Michael; Vogt, Thomas; Wild, Peter J (2012). A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS ONE, 7(6):e38222.

Moch, Holger (2012). An overview of renal cell cancer: Pathology and genetics. Seminars in Cancer Biology, 23(1):3-9.

Moch, H (2012). Biomarker für Nierenkarzinome : Was ist gerechtfertigt? Der Pathologe, 33(2):278-281.

Lehr, Hans-Anton; Moch, Holger; Christen, Brigitte; Safret, Alexandra; Gugger, Mathias; Rössle, Matthias; von Gunten, Michael; Lemoine, Robert; Kurt, Ann-Marie; Caduff, Rosmarie; Walter, Arnold; Singer, Gad; Luscieti, Peter; Bannwart, Fridolin; Genton, Claude Y (2012). Board examination for anatomical pathology in Switzerland: two intense days to verify professional competence. Virchows Archiv, 461(1):87-92.

Reiner, C S; Goetti, R; Eberli, D; Klotz, E; Boss, A; Pfammatter, T; Frauenfelder, T; Moch, H; Sulser, T; Alkadhi, H (2012). CT perfusion of renal cell carcinoma: Impact of volume coverage on quantitative analysis. Investigative Radiology, 47(1):33-40.

Gupta, Ruta; Billis, Athanase; Shah, Rajal B; Moch, Holger; Osunkoya, Adeboye O; Jochum, Wolfram; Hes, Ondrej; Bacchi, Carlos E; de Castro, Marilia G; Hansel, Donna E; Zhou, Ming; Vankalakunti, Mahesha; Salles, Paulo G; Cabrera, Rafael A; Gown, Allen M; Amin, Mahul B (2012). Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship. American Journal of Surgical Pathology, 36(9):1265-1278.

Morra, L; Rechsteiner, M; Casagrande, S; von Teichman, A; Schraml, P; Moch, H; Soltermann, A (2012). Characterization of periostin isoform pattern in non-small cell lung cancer. Lung Cancer, 76(2):183-190.

Varga, Z; Tubbs, R R; Wang, Z; Sun, Y; Noske, A; Kradolfer, D; Bosshard, G; Jochum, W; Moch, H; Öhlschlegel, C (2012). Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer. Breast Cancer Research and Treatment, 132(3):925-935.

Denkert, C; Kronenwett, R; Schlake, W; Bohmann, K; Penzel, R; Weber, K E; Höfler, H; Lehmann, U; Schirmacher, P; Specht, K; Rudas, M; Kreipe, H H; Schraml, P; Schlake, G; Bago-Horvath, Z; Tiecke, F; Varga, Z; Moch, H; Schmidt, M; Prinzler, J; Kerjaschki, D; Sinn, B V; Müller, B M; Filipits, M; Petry, C; Dietel, M (2012). Decentral gene expression analysis for ER+/Her2- breast cancer: results of a proficiency testing program for the EndoPredict assay. Virchows Archiv, 460(3):251-259.

Schoenewolf, Nicola L; Dummer, Reinhard; Mihic-Probst, Daniela; Moch, Holger; Simcock, Mathew; Ochsenbein, Adrian; Gillessen, Silke; Schraml, Peter; von Moos, Roger (2012). Detecting BRAF mutations in formalin-fixed melanoma: experiences with two state-of-the-art techniques. Case Reports in Oncology, 5(2):280-289.

Schwanda-Burger, Stefanie; Moch, Holger; Muntwyler, Jörg; Salomon, Franco (2012). Diagnostic errors in the new millennium: a follow-up autopsy study. Modern Pathology, 25(6):777-783.

Thunnissen, Erik; Bubendorf, Lukas; Dietel, Manfred; Elmberger, Göran; Kerr, Keith; Lopez-Rios, Fernando; Moch, Holger; Olszewski, Wlodzimierz; Pauwels, Patrick; Penault-Llorca, Frédérique; Rossi, Giulio (2012). EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations. Virchows Archiv, 461(3):245-257.

Wolf, Monika Julia; Hoos, Alexandra; Bauer, Judith; Boettcher, Steffen; Knust, Markus; Weber, Achim; Simonavicius, Nicole; Schneider, Christoph; Lang, Matthias; Stürzl, Michael; Croner, Roland S; Konrad, Andreas; Manz, Markus G; Moch, Holger; Aguzzi, Adriano; van Loo, Geert; Pasparakis, Manolis; Prinz, Marco; Borsig, Lubor; Heikenwalder, Mathias (2012). Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell, 22(1):91-105.

Minner, S; Rump, D; Tennstedt, P; Simon, R; Burandt, E; Terracciano, L; Moch, H; Wilczak, W; Bokemeyer, C; Fisch, M; Sauter, G; Eichelberg, C (2012). Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma. Cancer, 118(5):1268-1275.

Zhou, Weibin; Otto, Edgar A; Cluckey, Andrew; Airik, Rannar; Hurd, Toby W; Chaki, Moumita; Diaz, Katrina; Lach, Francis P; Bennett, Geoffrey R; Gee, Heon Yung; Ghosh, Amiya K; Natarajan, Sivakumar; Thongthip, Supawat; Veturi, Uma; Allen, Susan J; Janssen, Sabine; Ramaswami, Gokul; Dixon, Joanne; Burkhalter, Felix; Spoendlin, Martin; Moch, Holger; Mihatsch, Michael J; Verine, Jerome; Reade, Richard; Soliman, Hany; Godin, Michel; Kiss, Denes; Monga, Guido; Mazzucco, Gianna; Amann, Kerstin; Artunc, Ferruh; Newland, Ronald C; Wiech, Thorsten; Zschiedrich, Stefan; Huber, Tobias B; Friedl, Andreas; Slaats, Gisela G; Joles, Jaap A; Goldschmeding, Roel; Washburn, Joseph; Giles, Rachel H; Levy, Shawn; Smogorzewska, Agata; Hildebrandt, Friedhelm (2012). FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nature Genetics, 44(8):910-915.

von Moos, R; Seifert, B; Simcock, M; Goldinger, S M; Gillessen, S; Ochsenbein, A; Michielin, O; Cathomas, R; Schläppi, M; Moch, H; Schraml, P H; Mihic-Probst, D; Mamot, C; Schönewolf, N; Dummer, R (2012). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Annals of Oncology, 23(2):531-536.

Algaba, F; Delahunt, B; Berney, D M; Camparo, P; Compérat, E; Griffiths, D; Kristiansen, G; Lopez-Beltran, A; Martignoni, G; Moch, H; Montironi, R; Varma, M; Egevad, L (2012). Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European Network of Uropathology. Journal of Clinical Pathology, 65(2):106-113.

Walter, Bernhard; Hartmann, Arndt; Hofstädter, Ferdinand; Junker, Kerstin; Moch, Holger; Bertz, S; Denzinger, Stefan; Otto, Wolfgang; Gajda, Mieczyslaw; Stoehr, C G (2012). Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria. Virchows Archiv, 460(3):343-352.

Peifer, Martin; Fernández-Cuesta, Lynnette; Sos, Martin L; et al; Soltermann, Alex; Moch, Holger (2012). Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nature Genetics, 44(10):1104-1110.

Beleut, Manfred; Zimmermann, Philip; Baudis, Michael; Bruni, Nicole; Bühlmann, Peter; Laule, Oliver; Luu, Van-Duc; Gruissem, Wilhelm; Schraml, Peter; Moch, Holger (2012). Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome. BMC Cancer, 12:310.

Wiedl, T; Collaud, S; Hillinger, S; Arni, S; Burgess, C; Kroll, W; Schraml, P; Soltermann, A; Moch, H; Weder, W (2012). KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinoma. Cancer Genomics & Proteomics, 9(1):51-54.

Fritzsche, Florian Rudolf; Ramach, Constanze; Soldini, Davide; Caduff, Rosmarie; Tinguely, Marianne; Cassoly, Estelle; Moch, Holger; Stewart, Antony (2012). Occupational health risks of pathologists - results from a nationwide online questionnaire in Switzerland. BMC Public Health, 12:1054.

Moch, H; Blank, P R; Dietel, M; Elmberger, G; Kerr, K M; Palacios, J; Penault-Llorca, F; Rossi, G; Szucs, T D (2012). Personalized cancer medicine and the future of pathology. Virchows Archiv, 460(1):3-8.

Dettmer, Matthias; Schmitt, Anja; Steinert, Hans; Moch, Holger; Komminoth, Paul; Perren, Aurel (2012). Poorly differentiated oncocytic thyroid carcinoma - diagnostic implications and outcome. Histopathology, 60(7):1045-1051.

Schraml, P; von Teichman, A; Mihic-Probst, D; Simcock, M; Ochsenbein, A; Dummer, R; Michieilin, O; Seifert, B; Schläppi, M; Moch, H; von Moos, R (2012). Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07. Oncology Reports, 28(2):654-658.

Brandt, S; Lohe, B; Vogetseder, A; Rüdiger, T; Moch, H; Bode, P (2012). Primitiver neuroektodermaler Tumor im Hoden: Molekulare Analyse und Diskussion der Entstehung. Der Pathologe:1-4.

Gerstung, Moritz; Beisel, Christian; Rechsteiner, Markus; Wild, Peter; Schraml, Peter; Moch, Holger; Beerenwinkel, Niko (2012). Reliable detection of subclonal single-nucleotide variants in tumour cell populations. Nature Communications, 3:811.

Wulf, Marie-Angela; Bode, Beata; Zimmermann, Dieter; Rufibach, Kaspar; Weder, Walter; Moch, Holger; Soltermann, Alex; Tischler, Verena (2012). Silver-enhanced In Situ Hybridization for Determination of EGFR Copy Number Alterations in Non-Small Cell Lung Cancer. The American journal of surgical pathology, 36(12):1801-1808.

Shakhova, Olga; Zingg, Daniel; Schaefer, Simon M; Hari, Lisette; Civenni, Gianluca; Blunschi, Jacqueline; Claudinot, Stéphanie; Okoniewski, Michal; Beermann, Friedrich; Mihic-Probst, Daniela; Moch, Holger; Wegner, Michael; Dummer, Reinhard; Barrandon, Yann; Cinelli, Paolo; Sommer, Lukas (2012). Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nature Cell Biology, 14(8):882-890.

Varga, Z; Moelans, C B; Zuerrer-Hardi, U; Ramach, C; Behnke, S; Kristiansen, G; Moch, H (2012). Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes. Breast Cancer Research and Treatment, 133(3):929-935.

Mihic-Probst, Daniela; Ikenberg, Kristian; Tinguely, Marianne; Schraml, Peter; Behnke, Silvia; Seifert, Burkhardt; Civenni, Gianluca; Sommer, Lukas; Moch, Holger; Dummer, Reinhard (2012). Tumor cell plasticity and angiogenesis in human melanomas. PLoS ONE, 7(3):e33571.

von Teichman, Adriana; Storz, Martina; Dettwiler, Susanne; Moch, Holger; Schraml, Peter (2012). Whole genome and transcriptome amplification: practicable tools for sustainable tissue biobanking? Virchows Archiv, 461(5):571-580.

Wild, Peter J; Ikenberg, Kristian; Fuchs, Thomas J; Rechsteiner, Markus; Georgiev, Strahil; Fankhauser, Niklaus; Noske, Aurelia; Roessle, Matthias; Caduff, Rosmarie; Dellas, Athanassios; Fink, Daniel; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine, 4(8):808-824.

2011

Sharma, A; Bode, B; Wenger, R H; Lehmann, K; Sartori, A A; Moch, H; Knuth, A; von Boehmer, L; van den Broek, Maries (2011). Gamma-radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo. PLoS ONE, 6(11):e28217.

Moch, H (2011). Dokumentation der diagnostischen Qualität im Krankenhaus: Auswertung der Autopsieberichte. Der Pathologe, 32(Sup 2):282-286.

Suwaki, N; Vanhecke, E; Atkins, K M; Graf, M; Swabey, K; Huang, P; Schraml, P; Moch, H; Cassidy, A M; Brewer, D; Al-Lazikani, B; Workman, P; De-Bono, J; Kaye, S B; Larkin, J; Gore, M E; Sawyers, C L; Nelson, P; Beer, T M; Geng, H; Gao, L; Qian, D Z; Alumkal, J J; Thomas, G; Thomas, G V (2011). A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma. Science Translational Medicine, 3(85):85ra47.

Noske, A; Zimmermann, A K; Caduff, R; Varga, Z; Fink, D; Moch, H; Kristiansen, G (2011). Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer. Virchows Archiv, 459(1):91-97.

Arbogast, S; Behnke, S; Opitz, I; Stahel, R A; Seifert, B; Weder, W; Moch, H; Soltermann, A (2011). Automated ERCC1 Immunohistochemistry in Non-small Cell Lung Cancer: Comparison of anti-ERCC1 Antibodies 8F1, D-10, and FL-297. Applied Immunohistochemistry & Molecular Morphology, 19(2):99-105.

Soltermann, A; Kilgus-Hawelski, S; Behnke, S; Storz, M; Moch, H; Bode, B (2011). Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10. Journal of Clinical Bioinformatics, 1:25.

Esterházy, D; Stützer, I; Wang, H; Rechsteiner, M P; Beauchamp, J; Döbeli, H; Hilpert, H; Matile, H; Prummer, M; Schmidt, A; Lieske, N; Boehm, B; Marselli, L; Bosco, D; Kerr-Conte, J; Aebersold, R; Spinas, G A; Moch, H; Migliorini, C; Stoffel, M (2011). Bace2 is a β cell-enriched protease that regulates pancreatic β cell function and mass. Cell Metabolism, 14(3):365-377.

Walter, D; Satheesha, S; Albrecht, P; Bornhauser, B C; D'Alessandro, V; Oesch, S M; Rehrauer, H; Leuschner, I; Koscielniak, E; Gengler, C; Moch, H; Bernasconi, M; Niggli, F K; Schäfer, B W (2011). CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres. PLoS ONE, 6(5):e19506.

Cima, I; Schiess, R; Wild, P; Kaelin, M; Schüffler, P; Lange, V; Picotti, P; Ossola, R; Templeton, A; Schubert, O; Fuchs, T; Leippold, T; Wyler, S; Zehetner, J; Jochum, W; Buhmann, J M; Cerny, T; Moch, H; Gillessen, S; Aebersold, R; Krek, W (2011). Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 108(8):3342-3347.

Brookman-May, S; May, M; Zigeuner, R; Shariat, S F; Scherr, D S; Chromecki, T; Moch, H; Wild, P J; Mohamad-Al-Ali, B; Cindolo, L; Wieland, W F; Schips, L; De Cobelli, O; Rocco, B; Santoro, L; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Dalpiaz, O; Hohenfellner, M; Gilfrich, C; Wirth, M P; Burger, M; Pahernik, S (2011). Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma. Journal of Urology, 186(6):2175-2181.

Algaba, F; Akaza, H; Lopez-Beltran, A; Martignoni, G; Moch, H; Montironi, R; Reuter, V (2011). Current pathology keys of renal cell carcinoma. European Urology, 60(4):634-643.

Der Pathologe : Organ der Deutschen Abteilung der Internationalen Akademie für Pathologie, der Deutschen, der Österreichischen und der Schweizerischen Gesellschaft für Pathologie und des Berufsverbandes Deutscher Pathologen. Edited by: Baretton, G B; Bubendorf, L; Büttner, R; Feiden, W; Kreipe, H; Kuhnen, C; Lax, S F; Mentzel, T; Moch, H; Saeger, W; Schirmacher, P; Schmidt, D; Schmitt-Gräff, A; Vieth, M; Werner, M; Schmid, K W (2011). Berlin, DE: Springer.

Huber, G F; Zullig, L; Soltermann, A; Roessle, M; Graf, N; Haerle, S K; Studer, G; Jochum, W; Moch, H; Stoeckli, S J (2011). Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC Cancer, 11:217.

Kristiansen, G; Hu, J; Wichmann, D; Stiehl, D P; Rose, M; Gerhardt, J; Bohnert, A; Ten Haaf, A; Moch, H; Raleigh, J; Varia, M A; Subarsky, P; Scandurra, F M; Gnaiger, E; Gleixner, E; Bicker, A; Gassmann, M; Hankeln, T; Dahl, E; Gorr, T A (2011). Endogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity: a role in tumor suppression? Journal of Biological Chemistry, 286(50):43417-43428.

Curioni-Fontecedro, Alessandra; Nuber, Natko; Mihic-Probst, Daniela; Seifert, Burkhardt; Soldini, Davide; Dummer, Reinhard; Knuth, Alexander; van den Broek, Maries; Moch, Holger (2011). Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients. PLoS ONE, 6(6):e21418.

Fritzsche, F R; Hasler, A; Bode, P K; Adams, H; Seifert, H H; Sulser, T; Moch, H; Barghorn, A; Kristiansen, G (2011). Expression of histone deacetylases 1, 2 and 3 in histological subtypes of testicular germ cell tumours. Histology and Histopathology, 26(12):1555-1561.

Huber, G F; Albinger-Hegyi, A; Soltermann, A; Roessle, M; Graf, N; Haerle, S K; Holzmann, D; Moch, H; Hegyi, I (2011). Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma. Cancer, 117(20):4659-4670.

Wagner, P L; Stiedl, A C; Wilbertz, T; Petersen, K; Scheble, V; Menon, R; Reischl, M; Mikut, R; Rubin, M A; Fend, F; Moch, H; Soltermann, A; Weder, W; Altorki, N K; Perner, S (2011). Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma. Lung Cancer, 74(1):118-123.

Civenni, Gianluca; Walter, Anne; Kobert, Nikita; Mihic-Probst, Daniela; Zipser, Marie; Belloni, Benedetta; Seifert, Burkhardt; Moch, Holger; Dummer, Reinhard; van den Broek, Maries; Sommer, Lukas (2011). Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Research, 71(8):3098-3109.

Butsch, R; Waelti, S L; Schaerer, S; Braun, J; Korol, D; Probst-Hensch, N; Moch, H; Kurrer, M (2011). Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma. Leukemia and Lymphoma, 52(7):1230-1238.

Mortezavi, A; Hermanns, T; Seifert, H H; Baumgartner, M; Provenzano, M; Sulser, T; Burger, M; Montani, M; Ikenberg, K; Hofstaedter, F; Hartmann, A; Jaggi, R; Moch, H; Kristiansen, G; Wild, P J (2011). KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 17(5):1111-1121.

Blank, P R; Moch, H; Szucs, T D; Schwenkglenks, M (2011). KRAS and BRAF mutation analysis in metastatic colorectal cancer: a cost-effectiveness analysis from a Swiss perspective. Clinical Cancer Research, 17(19):6338-6346.

Doberstein, K; Schramme, A; Lee, S B; Blaheta, R A; Wedel, S; Moch, H; Schraml, P; Pfeilschifter, J; Kristiansen, G; Gutwein, P (2011). L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells. Carcinogenesis, 32(3):262-270.

Tischler, V; Pfeifer, M; Hausladen, S; Schirmer, U; Bonde, A K; Kristiansen, G; Sos, M L; Weder, W; Moch, H; Altevogt, P; Soltermann, A (2011). L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Molecular Cancer, 10:127.

von Boehmer, Lotta; Keller, Lukas; Mortezavi, Ashkan; Provenzano, Maurizio; Sais, Giovanni; Hermanns, Thomas; Sulser, Tullio; Jungbluth, Achim A; Old, Lloyd J; Kristiansen, Glen; van den Broek, Maries; Moch, Holger; Knuth, Alexander; Wild, Peter J (2011). MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer. PLoS ONE, 6(7):e21366.

Bode, P K; Barghorn, A; Fritzsche, F R; Riener, M O; Kristiansen, G; Knuth, A; Moch, H (2011). MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors. Modern Pathology, 24(6):829-835.

Hammerman, P S; Sos, M L; Ramos, A H; Xu, C; Dutt, A; Zhou, W; Brace, L E; Woods, B A; Lin, W; Zhang, J; Deng, X; Lim, S M; Heynck, S; Peifer, M; Simard, J R; Lawrence, M S; Onofrio, R C; Salvesen, H B; Seidel, D; Zander, T; Heuckmann, J M; Soltermann, A; Moch, H; Koker, M; Leenders, F; Gabler, F; Querings, S; Ansén, S; Brambilla, E; Brambilla, C; Lorimier, P; Brustugun, O T; Helland, A; Petersen, I; Clement, J H; Groen, H; Timens, W; Sietsma, H; Stoelben, E; Wolf, J; Beer, D G; Tsao, M S; Hanna, M; Hatton, C; Eck, M J; Janne, P A; Johnson, B E; Winckler, W; Greulich, H; Bass, A J; Cho, J; Rauh, D; Gray, N S; Wong, K K; Haura, E B; Thomas, R K; Meyerson, M (2011). Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discovery, 1(1):78-89.

Choschzick, M; Oosterwijk, E; Müller, V; Woelber, L; Simon, R; Moch, H; Tennstedt, P (2011). Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer. Virchows Archiv, 459(2):193-200.

Morra, L; Moch, H (2011). Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update. Virchows Archiv, 459(5):465-475.

Dettmer, M; Schmitt, A; Steinert, H; Haldemann, A; Meili, A; Moch, H; Komminoth, P; Perren, A (2011). Poorly differentiated thyroid carcinomas: How much poorly differentiated is needed? American Journal of Surgical Pathology, 35(12):1866-1872.

Blyszczuk, P; Germano, D; Stein, S; Moch, H; Matter, C M; Beck-Schimmer, B; Lüscher, T F; Eriksson, U; Kania, G (2011). Profibrotic potential of Prominin-1+ epithelial progenitor cells in pulmonary fibrosis. Respiratory Research, 12:126.

Viehl, C T; Langer, I; Guller, U; Zanetti-Dällenbach, R; Moch, H; Wight, E; Oertli, D; Zuber, M (2011). Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients. Journal of Surgical Oncology, 103(6):531-533.

Morra, L; Rechsteiner, M; Casagrande, S; Duc Luu, V; Santimaria, R; Diener, P A; Sulser, T; Kristiansen, G; Schraml, P; Moch, H; Soltermann, A (2011). Relevance of periostin splice variants in renal cell carcinoma. American Journal of Pathology, 179(3):1513-1521.

Maier, S; Wilbertz, T; Braun, M; Scheble, V; Reischl, M; Mikut, R; Menon, R; Nikolov, P; Petersen, K; Beschorner, C; Moch, H; Kakies, C; Protzel, C; Bauer, J; Soltermann, A; Fend, F; Staebler, A; Lengerke, C; Perner, S (2011). SOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Human Pathology, 42(8):1078-1088.

Wilbertz, T; Wagner, P; Petersen, K F; Stiedl, A C; Scheble, V J; Maier, S; Reischl, M; Mikut, R; Altorki, N K; Moch, H; Fend, F; Staebler, A; Bass, A J; Meyerson, M; Rubin, M A; Soltermann, A; Lengerke, C; Perner, S (2011). SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Modern Pathology, 24(7):944-953.

Fritzsche, F R; Pianca, S; Gaspert, A; Varga, Z; Wang, L; Farrell, M P; Chen, X B; Hirsch, H H; Springer, E; Fehr, T; Myles, J; Tubbs, R; Moch, H (2011). Silver-enhanced in situ hybridization for detection of polyomavirus DNA in patients with BK virus nephropathy. Diagnostic Molecular Pathology, 20(2):105-110.

Theurillat, J P; Metzler, S C; Henzi, N; Djouder, N; Helbling, M; Zimmermann, A K; Jacob, F; Soltermann, A; Caduff, R; Heinzelmann-Schwarz, V; Moch, H; Krek, W (2011). URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell, 19(3):317-332.

Rechsteiner, M P; von Teichman, A; Nowicka, A; Sulser, T; Schraml, P; Moch, H (2011). VHL gene mutations and their effects on hypoxia inducible factor HIF{alpha}: Identification of potential driver and passenger mutations. Cancer Research, 71(16):5500-5511.

Teichman, A V; Compérat, E; Behnke, S; Storz, M; Moch, H; Schraml, P (2011). VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma. Modern Pathology, 24(4):571-578.

Sharma, Anu; Bode, Beata; Wenger, Roland H; Lehmann, Kuno; Sartori, Alessandro A; Moch, Holger; Knuth, Alexander; von Boehmer, Lotta; van den Broek, Maries (2011). γ-radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo. PLoS ONE, 6(11):e28217.

2010

Giger, O; Caduff, R; O'Meara, A; Diener, P A; Knuth, A; Jäger, D; Moch, H; Varga, Z (2010). Frequent expression of the breast differentiation antigen NY-BR-1 in mammary and extramammary Paget's disease. Pathology international, 60(11):726-734.

Nuber, Natko; Curioni-Fontecedro, Alessandra; Matter, Claudia; Soldini, Davide; Tiercy, Jean Marie; von Boehmer, Lotta; Moch, Holger; Dummer, Reinhard; Knuth, Alexander; van den Broek, Maries (2010). Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 107(34):15187-15192.

Walter, Anne; Barysch, Marjam J; Behnke, Silvia; Dziunycz, Piotr; Schmid, Bruno; Ritter, Erika; Gnjatic, Sacha; Kristiansen, Glen; Moch, Holger; Knuth, Alexander; Dummer, Reinhard; van den Broek, Maries (2010). Cancer testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas. Clinical Cancer Research, 16(14):3562-3570.

Kristiansen, G; Rose, M; Geisler, C; Fritzsche, F R; Gerhardt, J; Lüke, C; Ladhoff, A-M; Knüchel, R; Dietel, M; Moch, H; Varga, Z; Theurillat, J-P; Gorr, T A; Dahl, E (2010). Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. British Journal of Cancer, 102(12):1736-1745.

Albinger-Hegyi, A; Stoeckli, S J; Schmid, S; Storz, M; Iotzova, G; Probst-Hensch, N M; Rehrauer, H; Tinguely, M; Moch, H; Hegyi, I (2010). Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC). International Journal of Cancer, 126(11):2653 -2662.

Moch, H (2010). Cystic renal tumors: new entities and novel concepts. Advances in Anatomic Pathology, 17(3):209-14.

Schramm, A; Opitz, I; Thies, S; Seifert, B; Moch, H; Weder, W; Soltermann, A (2010). Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma. European Journal of Cardio-Thoracic Surgery, 37(3):566-572.

Moch, H (2010). Neue Aspekte der Pathologie des Nierenzellkarzinoms. Der Onkologe, 16(2):131-139.

Paner, G P; Amin, M B; Alvarado-Cabrero, I; Young, A N; Stricker, H J; Moch, H; Lyles, R H (2010). A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade. American Journal of Surgical Pathology, 34(9):1233-1240.

Leuenberger, M; Frigerio, S; Wild, P J; Noetzli, F; Korol, D; Zimmermann, D R; Gengler, C; Probst-Hensch, N M; Moch, H; Tinguely, M (2010). AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations. Modern Pathology, 23(2):177-186.

Sutter, R; Shakhova, O; Bhagat, H; Behesti, H; Sutter, C; Penkar, S; Santuccione, A; Bernays, R L; Heppner, F L; Schüller, U; Grotzer, M; Moch, H; Schrami, P; Marino, S (2010). Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Oncogene, 29(12):1845-1856.

Tischler, Verena; Fritzsche, Florian R; Gerhardt, Josefine; Jäger, Christian; Stephan, Carsten; Jung, Klaus; Dietel, Manfred; Moch, Holger; Kristiansen, Glen (2010). Comparison of the diagnostic value of fatty acid synthase (FASN) with alpha-methylacyl-CoA racemase (AMACR) as prostatic cancer tissue marker. Histopathology, 56(6):811-815.

Theurillat, J P; Dreier, B; Nagy-Davidescu, G; Seifert, Burkhardt; Behnke, S; Zürrer-Härdi, U; Ingold, F; Plückthun, A; Moch, H (2010). Designed ankyrin repeat proteins: a novel tool for testing epidermal growth factor receptor 2 expression in breast cancer. Modern Pathology, 23(9):1289-1297.

Fritzsche, F R; Bode, P K; Moch, H; Kristiansen, G; Varga, Z; Bode, B (2010). Determination of the Her-2/neu gene amplification status in cytologic breast cancer specimens using automated silver-enhanced in-situ hybridization (SISH). American Journal of Surgical Pathology, 34(8):1180-1185.

Soltermann, A; Opitz, I; Tischler, V; Thies, S; Morra, L; Stahel, R A; Weder, W; Moch, H (2010). EMT in NSCLC and malignant pleural mesothelioma. memo - Magazine of European Medical Oncology, 3(4):180-184.

Riener, M O; Fritzsche, F R; Soll, C; Pestalozzi, B C; Probst-Hensch, N M; Clavien, P A; Jochum, W; Soltermann, A; Moch, H; Kristiansen, G (2010). Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas. Histopathology, 56(5):600-606.

Schmid, S; Tinguely, M; Cione, P; Moch, H; Bode, B (2010). Flow cytometry as an accurate tool to complement fine needle aspiration cytology in the diagnosis of low grade malignant lymphomas. Cytopathology, 22(6):397-406.

Weiss, J; Sos, M L; Seidel, D; et al; Soltermann, A; Moch, H (2010). Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Science Translational Medicine, 2(62):62ra93.

Blank, P R; Schwenkglenks, M; Moch, H; Szucs, T D (2010). Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost-effectiveness analysis of different predictive assay strategies. Breast Cancer Research and Treatment, 124(2):497-507.

Probst-Hensch, N M; Steiner, J H B; Schraml, P; Varga, Z; Zürrer-Härdi, U; Storz, M; Korol, D; Fehr, M K; Fink, D; Pestalozzi, B C; Lütolf, U M; Theurillat, J P; Moch, H (2010). IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity. Clinical Cancer Research, 16(3):1025-1032.

Ikenberg, K; Fritzsche, F R; Zuerrer-Haerdi, U; Hofmann, I; Hermanns, T; Seifert, H; Müntener, M; Provenzano, M; Sulser, T; Behnke, S; Gerhardt, J; Mortezavi, A; Wild, P; Hofstädter, F; Burger, M; Moch, H; Kristiansen, G (2010). Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores. BMC Cancer, 10:341.

Weber, A; Zimmermann, D R; Moch, H (2010). KRAS-Mutationsstatus und kolorektales Karzinom - Diagnostik. In: Köberle, D; Gautschi, O. KRAS-Mutationsstatus und kolorektales Karzinom. Bremen: UNI-MED Science, UNI-MED Verlag AG, 29-33.

Dahinden, C; Ingold, B; Wild, P; Boysen, G; Luu, V D; Montani, M; Kristiansen, G; Sulser, T; Bühlmann, P; Moch, H; Schraml, P (2010). Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clinical Cancer Research, 16(1):88-98.

Studer, A M; Limbach, L K; Van Duc, L; Krumeich, F; Athanassiou, E K; Gerber, L C; Moch, H; Stark, W J (2010). Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles. Toxicology Letters, 197(3):169-174.

Fritzsche, F R; Reineke, T; Morawietz, L; Kristiansen, G; Dietel, M; Fink, D; Rageth, C; Honegger, C; Caduff, R; Moch, H; Varga, Z (2010). Pathological processing techniques and final diagnosis of breast cancer sentinel lymph nodes. Annals of Surgical Oncology, 17(11):2892-2898.

Akaza, H; Lopez-Beltran, A; Martignoni, G; Moch, H; Montironi, R; Reuter, V E (2010). Pathology of Renal Cancer. In: Kirkali, Z; Mulders, P. 1st EAU-ICD International Consultation on Kidney Cancer. Barcelona: ICUD, 47-72.

Tischler, V; Fritzsche, F R; Wild, P J; Stephan, C; Seifert, H H; Riener, M O; Hermanns, T; Mortezavi, A; Gerhardt, J; Schraml, P; Jung, K; Moch, H; Soltermann, A; Kristiansen, G (2010). Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer, 10:273.

Nilsson, K P R; Ikenberg, K; Aslund, A; Fransson, S; Konradsson, P; Röcken, C; Moch, H; Aguzzi, A (2010). Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy. American Journal of Pathology, 176(2):563-574.

Cueni, L N; Hegyi, I; Shin, J W; Albinger-Hegyi, A; Gruber, S; Kunstfeld, R; Moch, H; Detmar, M (2010). Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin. American Journal of Pathology, 177(2):1004-1016.

Montani, M; Heinimann, K; von Teichman, A; Rudolph, T; Perren, A; Moch, H (2010). VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease. The American Journal of Surgical Pathology, 34(6):806-815.

Moch, H (2010). Zystische Nierentumoren. Neue Tumortypen und aktuelle molekulare Erkenntnisse. Der Pathologe, 31(Sup 2):239-243.

2009

Fritzsche, F R; Kristiansen, G; Frauenfelder, T; Opitz, I; Bode, P; Moch, H; Montani, M (2009). Large mixed germ cell tumor in a young patient presenting as an intrapulmonary mass. Pathology - Research and Practice, 205(8):572-578.

Langer, I; Guller, U; Hsu-Schmitz, S F; Ladewig, A; Viehl, C T; Moch, H; Wight, E; Harder, F; Oertli, D; Zuber, M (2009). Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. European Journal of Surgical Oncology, 35(8):805-813.

Wild, P J; Fuchs, T; Stoehr, R; Zimmermann, D; Frigerio, S; Padberg, B; Steiner, I; Zwarthoff, E C; Burger, M; Denzinger, S; Hofstaedter, F; Kristiansen, G; Hermanns, T; Seifert, H H; Provenzano, M; Sulser, T; Roth, V; Buhmann, J M; Moch, H; Hartmann, A (2009). Detection of Urothelial Bladder Cancer Cells in Voided Urine Can Be Improved by a Combination of Cytology and Standardized Microsatellite Analysis. Cancer Epidemiology Biomarkers & Prevention, 18(6):1798-1806.

Balamurugan, K; Luu, V D; Kaufmann, M R; Hofmann, V S; Boysen, G; Barth, S; Bordoli, M R; Stiehl, D P; Moch, H; Schraml, P; Wenger, R H; Camenisch, G (2009). Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response. Oncogene:1-12.

Zellweger, T; Günther, S; Zlobec, I; Savic, S; Sauter, G; Moch, H; Mattarelli, G; Eichenberger, T; Curschellas, E; Rüfenacht, H; Bachmann, A; Gasser, T C; Mihatsch, M J; Bubendorf, L (2009). Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer. International Journal of Cancer, 124(9):2116-2123.

Dellas, A; Jundt, G; Sartorius, G; Schneider, M; Moch, H (2009). Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas. Clinical Cancer Research, 15(7):2456-2462.

Gutwein, P; Schramme, A; Voss, B; Abdel-Bakky, M S; Doberstein, K; Ludwig, A; Altevogt, P; Hansmann, M L; Moch, H; Kristiansen, G; Pfeilschifter, J (2009). Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinoma. Biochemical and Biophysical Research Communications (BBRC), 380(2):387-391.

Anlauf, M; Bauersfeld, J; Raffel, A; Koch, C A; Henopp, T; Alkatout, I; Schmitt, A; Weber, A; Kruse, M L; Braunstein, S; Kaserer, K; Brauckhoff, M; Dralle, H; Moch, H; Heitz, P U; Komminoth, P; Knoefel, W; Perren, A; Klöppel, G (2009). Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia. American Journal of Surgical Pathology, 33(3):339-346.

Issa, R M; Lebeau, A; Grob, T; Holst, F; Moch, H; Terracciano, L; Choschzick, M; Sauter, G; Simon, R (2009). Estrogen receptor gene amplification occurs rarely in ovarian cancer. Modern Pathology, 22(2):191-196.

Riener, M O; Stenner, F; Liewen, H; Soll, C; Breitenstein, S; Pestalozzi, B C; Samaras, P; Probst-Hensch, N M; Hellerbrand, C; Müllhaupt, B; Clavien, P A; Bahra, M; Neuhaus, P; Wild, P; Fritzsche, F; Moch, H; Jochum, W; Kristiansen, G (2009). Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology, 49(5):1602 -1609.

Langer, I; Guller, U; Berclaz, G; Koechli, O R; Moch, H; Schaer, G; Fehr, M K; Hess, T; Oertli, D; Bronz, L; Schnarwyler, B; Wight, E; Uehlinger, U; Infanger, E; Burger, D; Zuber, M (2009). Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Research and Treatment, 113(1):129-136.

Vasei, M; Modjtahedi, H; Ale-Booyeh, O; Mosallaei, A; Kajbafzadeh, A M; Shahriari, M; Ghaderi, A A; Soleymanpour, H; Kosari, F; Moch, H; Sauter, G (2009). Amplification and expression of EGFR and ERBB2 in Wilms tumor. Cancer Genetics and Cytogenetics, 194(2):88-95.

Kellner, A; Matschke, J; Bernreuther, C; Moch, H; Ferrer, I; Glatzel, M (2009). Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden. Annals of Neurology, 65(1):24-31.

Langer, I; Guller, U; Viehl, C T; Moch, H; Wight, E; Harder, F; Oertli, D; Zuber, M (2009). Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Annals of Surgical Oncology, 16(12):3366-3374.

Tölle, A; Jung, M; Lein, M; Johannsen, M; Miller, K; Moch, H; Jung, K; Kristiansen, G (2009). Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer? BMC Cancer, 9:248.

Sconocchia, Giuseppe; Spagnoli, Giulio C; Del Principe, Domenico; Ferrone, Soldano; Anselmi, Maurizio; Wongsena, Wachanan; Cervelli, Valerio; Schultz-Thater, Elke; Wyler, Stephen; Carafa, Vincenza; Moch, Holger; Terracciano, Luigi; Tornillo, Luigi (2009). Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction. Neoplasia, 11(7):662-671.

Giobbie-Hurder, A; Price, K N; Gelber, R D; et al; Varga, Z; Moch, H; Caduff, R (2009). Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer. Clinical Trials, 6(3):272-287.

Eichelberg, C; Junker, K; Ljungberg, B; Moch, H (2009). Diagnostic and Prognostic Molecular Markers for Renal Cell Carcinoma: A Critical Appraisal of the Current State of Research and Clinical Applicability. European Urology, 55(4):851-863.

Kempkensteffen, C; Fritzsche, F R; Johannsen, M; Weikert, S; Hinz, S; Dietel, M; Riener, M O; Moch, H; Jung, K; Krause, H; Miller, K; Kristiansen, G (2009). Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. BMC Cancer, 9:276.

Riener, M O; Wild, P J; Soll, C; Knuth, A; Jin, B; Jungbluth, A; Hellerbrand, C; Clavien, P A; Moch, H; Jochum, W (2009). Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma. International Journal of Cancer, 124(2):352-357.

Gutzwiller, Felix; Moch, Holger; Probst-Hensch, Nicole (2009). Geleitwort des Lenkungsausschusses des Krebsregisters des Kantons Zürich. In: Bopp, Matthias; Ebnöther, Eva; Probst-Hensch, Nicole. Krebs im Kanton Zürich : ein Bericht des Krebsregisters. Zürich: Institut für Sozial- und Präventivmedizin der Universität Zürich, V-VI.

Sørensen, K D; Wild, P J; Mortezavi, A; Adolf, K; Tørring, N; Heebøll, S; Ulhøi, B P; Ottosen, P; Sulser, T; Hermanns, T; Moch, H; Borre, M; Ørntoft, T F; Dyrskjøt, L (2009). Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 15(4):1400-1410.

Floros, X; Fuchs, T J; Rechsteiner, M P; Spinas, G; Moch, H; Buhmann, J M (2009). Graph-based pancreatic islet segmentation for early type 2 diabetes mellitus on histopathological tissue. In: Yang, G Z; Hawkes, D; Rueckert, D; Noble, A; Taylor, C. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2009, 12th International Conference, London, UK, September 20-24, 2009, Proceedings, Part 2. Berlin: Springer, 633-640.

Ingold, B; Schraml, P; Heppner, F L; Moch, H (2009). Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors. PLoS ONE, 4(3):e4775.

Boysen, G; Wollscheid, B; Bausch-Fluck, D; Schraml, P; Moch, H (2009). Identifizierung VHL-assoziierter Veränderungen im klarzelligen Nierenzellkarzinom : Anwendung von kombinierten Genom- und Expressionsanalysen. Der Pathologe, Suppl 2:188-192.

Soltermann, A; Moch, H (2009). Klinisch relevante Biomarker des nicht kleinzelligen Lungenkarzinoms. Diagnostik, Prognose, Therapie und Prävention. The Medical Journal (TMJ), 2009(4):26-29.

Luu, V D; Boysen, G; Struckmann, K; Casagrande, S; von Teichman, A; Wild, P J; Sulser, T; Schraml, P; Moch, H (2009). Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma. Clinical Cancer Research, 15(10):3297-3304.

Ghadjar, P; Blank-Liss, W; Simcock, M; Hegyi, I; Beer, K T; Moch, H; Aebersold, D M; Zimmer, Y (2009). MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers. Clinical and Experimental Metastasis, 26(7):809-815.

Beroukhim, R; Brunet, J P; Di Napoli, A; Mertz, K D; Seeley, A; Pires, M M; Linhart, D; Worrell, R A; Moch, H; Rubin, M A; Sellers, W R; Meyerson, M; Linehan, W M; Kaelin, W G; Signoretti, S (2009). Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Research, 69(11):4674-4681.

Gerstung, M; Baudis, M; Moch, H; Beerenwinkel, N (2009). Quantifying cancer progression with conjunctive Bayesian networks. Bioinformatics, 25(21):2809-2815.

Fuchs, T J; Haybaeck, J; Wild, P J; Heikenwalder, M; Moch, H; Aguzzi, A; Buhmann, J M (2009). Randomized tree ensembles for object detection in computational pathology. In: Bebis, G; et al. Advances in Visual Computing : 5th International Symposium, ISVC 2009, Las Vegas, NV, USA, November 30 - December 2, 2009, Proceedings, Part 1. Berlin: Springer, 367-380.

Moch, H; Artibani, W; Delahunt, B; Ficarra, V; Knuechel, R; Montorsi, F; Patard, J J; Stief, C G; Sulser, T; Wild, P J (2009). Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. European Urology, 56(4):636-643.

Perner, S; Wagner, P L; Soltermann, A; LaFargue, C; Tischler, V; Weir, B A; Weder, W; Meyerson, M; Giordano, T J; Moch, H; Rubin, M A (2009). TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival. Journal of Pathology, 217(1):65-72.

Schmitt, A M; Schmid, S; Rudolph, T; Anlauf, M; Prinz, C; Klöppel, G; Moch, H; Heitz, P U; Komminoth, P; Perren, A (2009). VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors. Endocrine-Related Cancer, 16(4):1219-1227.

Thoma, C R; Toso, A; Gutbrodt, K L; Reggi, S P; Frew, I J; Schraml, Peter; Hergovich, A; Moch, H; Meraldi, P; Krek, W (2009). VHL loss causes spindle misorientation and chromosome instability. Nature Cell Biology, 11(8):994-1001.

2008

Soltermann, A; Tischler, V; Arbogast, S; Braun, J; Probst-Hensch, N M; Weder, W; Moch, H; Kristiansen, G (2008). Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clinical Cancer Research, 14(22):7430-7437.

Moch, H (2008). Funktionen des VHL-Proteins bei Entstehung und Progression von Nierenzellkarzinomen. Der Pathologe, 29(Suppl.):149-152.

Moch, H (2008). Molekulare Basis der zielgerichteten Therapien bei metastasierenden Nierenzellkarzinomen. Der Pathologe, 29(Suppl.):184-186.

Waibel, R; Treichler, H; Schaefer, N G; van Staveren, D R; Mundwiler, S; Kunze, S; Küenzi, M; Alberto, R; Nüesch, J; Knuth, A; Moch, H; Schibli, R; Schubiger, P A (2008). New derivatives of vitamin B12 show preferential targeting of tumors. Cancer Research, 68(8):2904-2911.

Tinguely, M; Jenni, B; Knights, A; Lopes, B; Korol, D; Rousson, V; Curioni Fontecedro, A; Cogliatti, S B; Bittermann, A G; Schmid, U; Dommann-Scherrer, C; Maurer, R; Renner, C; Probst-Hensch, N M; Moch, H; Knuth, A; Zippelius, A (2008). MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome. Cancer Science, 99(4):720-725.

Varga, Z; Rageth, C; Saurenmann, E; Honegger, C; von Orelli, S; Fehr, M; Fink, D; Seifert, Burkhardt; Moch, H; Caduff, R (2008). Use of intraoperative stereomicroscopy for preventing loss of metastases during frozen sectioning of sentinel lymph nodes in breast cancer. Histopathology, 52(5):597-604.

Curioni-Fontecedro, A; Knights, A J; Tinguely, M; Nuber, N; Schneider, C; Thomson, C W; von Boehmer, I; Bossart, W; Pahlich, S; Gehring, H; Moch, H; Renner, C; Knuth, A; Zippelius, A (2008). MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma. Leukemia, 22(8):1646-1648.

Steu, S; Baucamp, M; von Dach, G; Bawohl, M; Dettwiler, S; Storz, M; Moch, H; Schraml, P (2008). A procedure for tissue freezing and processing applicable to both intra-operative frozen section diagnosis and tissue banking in surgical pathology. Virchows Archiv, 452(3):305-312.

Zhao, J; Moch, H (2008). Absence of JH2 domain mutation of the tyrosine kinase JAK2 in renal cell carcinomas. Acta Oncologica, 47(3):474-476.

Mertz, K D; Demichelis, F; Sboner, A; Hirsch, M S; Cin, P D; Struckmann, K; Storz, M; Scherrer, S; Schmid, D M; Strebel, R T; Probst-Hensch, N M; Gerstein, M; Moch, H; Rubin, M A (2008). Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. International Journal of Cancer, 123(3):569-576.

Fritzsche, F R; Oelrich, B; Johannsen, M; Kristiansen, I; Moch, H; Jung, K; Kristiansen, G (2008). Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas. Clinical Cancer Research, 14(21):7035-7042.

Frew, I J; Minola, A; Georgiev, S; Hitz, M; Moch, H; Richard, S; Vortmeyer, A O; Krek, W (2008). Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia. Molecular and Cellular Biology, 28(14):4536-4548.

Fuchs, T J; Wild, P J; Moch, H; Buhmann, J M (2008). Computational pathology analysis of tissue microarrays predicts survival of renal clear cell carcinoma patients. In: Metaxas, D. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2008. Pt. 2. Berlin: Springer, 1-8.

Zhao, J; Leonard, C; Gemsenjäger, E; Heitz, P U; Moch, H; Odermatt, B (2008). Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling. Oncology Reports, 19(2):329-337.

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Perner, Sven; Wagner, Patrick L; Demichelis, Francesca; Mehra, Rohit; LaFargue, Christopher J; Moss, Benjamin J; Arbogast, Stefanie; Soltermann, Alex; Weder, Walter; Giordano, Thomas J; Beer, David G; Rickman, David S; Chinnaiyan, Arul M; Moch, Holger; Rubin, Mark A (2008). EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia, 10(3):298-302.

Fritzsche, F R; Riener, M O; Dietel, M; Moch, H; Jung, K; Kristiansen, G (2008). GOLPH2 expression in renal cell cancer. BMC Urology, 8:15.

Kristiansen, G; Fritzsche, F R; Wassermann, K; Jäger, C; Tölle, A; Lein, M; Stephan, C; Jung, K; Pilarsky, C; Dietel, M; Moch, H (2008). GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. British Journal of Cancer, 99(6):939-948.

Reschke, M; Mihic-Probst, D; van der Horst, E H; Knyazev, P; Wild, P J; Hutterer, M; Meyer, S; Dummer, R; Moch, H; Ullrich, A (2008). HER3 is a determinant for poor prognosis in melanoma. Clinical Cancer Research, 14(16):5188-5197.

Vasei, M; Moch, H; Mousavi, A; Kajbafzadeh, A M; Sauter, G (2008). Immunohistochemical profiling of Wilms tumor: a tissue microarray study. Applied Immunohistochemistry & Molecular Morphology, 16(2):128-134.

Tinguely, M; Hofmann, A; Bausch-Fluck, D; Moch, H; Wollscheid, B (2008). Immunophenotyping without antibodies. New perspectives for lymphoma characterization. Der Pathologe, 29 Suppl:314-316.

Tinguely, M; Hofmann, A; Bausch-Fluck, D; Moch, H; Wollscheid, B (2008). Immunphänotypisierung ohne Antikörper: Neue Perspektiven in der Lymphomcharakterisierung. Der Pathologe, 29(Suppl.):314-316.

Schmitt, A M; Riniker, F; Anlauf, M; Schmid, S; Soltermann, A; Moch, H; Heitz, P U; Klöppel, G; Komminoth, P; Perren, A (2008). Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases. American Journal of Surgical Pathology, 32(3):420-425.

Soltermann, A; Ossola, R; Kilgus-Hawelski, S; von Eckardstein, A; Suter, T; Aebersold, R; Moch, H (2008). N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics. Cancer, 114(2):124-133.

Nizze, H; Kerjaschki, D; Moch, H (2008). Niere. In: Böcker, W; et al. Pathologie. München, DE: Elsevier, Urban & Fischer, 853-888.

Lebeau, A; Grob, T J; Holst, F; Seyedi-Fazlollahi, N; Moch, H; Terracciano, L; Turzynski, A; Choschzick, M; Sauter, G; Simon, R (2008). Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions. Journal of Pathology, 216(2):151-157.

Opitz, I; Soltermann, A; Abaecherli, M; Hinterberger, M; Probst-Hensch, N; Stahel, R; Moch, H; Weder, W (2008). PTEN expression is a strong predictor of survival in mesothelioma patients. European Journal of Cardio-Thoracic Surgery, 33(3):502-506.

Pathologie. Edited by: Böcker, W; Denk, H; Heitz, P U; Moch, H (2008). München, DE: Elsevier, Urban & Fischer.

Moch, H; Komminoth, P; Zimmermann, D R; Odermatt, B; Probst-Hensch, N M; Bopp, M (2008). Pathologie: Aufgaben und Methoden. In: Böcker, W; Denk, H; Heitz, P U. Pathologie. München, Jena: Urban und Fischer bei Elsevier, 3-34.

Spahn, Donat R; Moch, Holger; Hofmann, A; Isbister, J P (2008). Patient Blood Management: the pragmatic solution for the problems with blood transfusions. Anesthesiology, 109(6):951-953.

Ingold, B; Wild, P J; Nocito, A; Amin, M B; Storz, M; Heppner, F L; Moch, H (2008). Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma. Histopathology, 52(6):674-681.

Repetitorium Pathologie. Edited by: Böcker, W; Denk, H; Heitz, P U; Moch, H (2008). München, DE: Elsevier, Urban & Fischer.

Garbrecht, N; Anlauf, M; Schmitt, A; Henopp, T; Sipos, B; Raffel, A; Eisenberger, C F; Knoefel, W T; Pavel, M; Fottner, C; Musholt, T J; Rinke, A; Arnold, R; Berndt, U; Plöckinger, U; Wiedenmann, B; Moch, H; Heitz, P U; Komminoth, P; Perren, A; Klöppel, G (2008). Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity. Endocrine-Related Cancer, 15(1):229-241.

Schraml, P; Frew, I J; Thoma, C R; Boysen, G; Struckmann, K; Krek, W; Moch, H (2008). Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia. Modern Pathology, 22(1):31-36.

Stallmach, T; Klöppel, G; Roth, J; Spinas, G A (2008). Stoffwechselerkrankungen. In: Böcker, W; Denk, H; Heitz, P U; Moch, H. Pathologie. München: Urban und Fischer, 1123-1147.

Weber, Achim; Kristiansen, Ilka; Johannsen, Manfred; Oelrich, Beibei; Scholmann, Katharina; Gunia, Sven; Mayr, Matthias; Meyer, Hellmuth-Alexander; Behnke, Silvia; Moch, Holger; Kristiansen, Glen (2008). The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer. BMC Cancer, 8:369.

Luu, V D; Fischer, B; von Teichman, A; Boysen, G; Mertz, K; Zimmermann, P; Moch, H; Schraml, P (2008). Von-Hippel-Lindau-Gen-Mutationstypen: Assoziation mit Genexpressionssignaturen in klarzelligen Nierenzellkarzinomen. Der Pathologe, 29(Suppl.):303-307.

Fuchs, T J; Lange, T; Wild, P J; Moch, H; Buhmann, J M (2008). Weakly supervised cell nuclei detection and segmentation on tissue microarrays of renal clear cell carcinoma. In: Rigoll, G. Pattern Recognition. Berlin, DE: Springer, 173-182.

Frew, I J; Thoma, C R; Georgiev, S; Minola, A; Hitz, M; Montani, M; Moch, H; Krek, W (2008). pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation. EMBO Journal, 27(12):1747-1757.

Struckmann, K; Mertz, K; Steu, S; Storz, M; Staller, P; Krek, W; Schraml, P; Moch, H (2008). pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma. Journal of Pathology, 214(4):464-471.

2007

Bruder, Elisabeth; Moch, Holger; Ehrlich, David; Leuschner, Ivo; Harms, Dieter; Argani, Pedram; Briner, Jakob; Graf, Norbert; Selle, Barbara; Rufle, Alex; Paulussen, Michael; Koesters, Robert (2007). Wnt signaling pathway analysis in renal cell carcinoma in young patients. Modern Pathology, 20(12):1217-1229.

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Storz, M; Probst-Hensch, N M; Seifert, Burkhardt; Fehr, M K; Fink, D; Ferrone, S; Pestalozzi, B; Jungbluth, A A; Chen, Y T; Jäger, D; Knuth, A; Moch, H (2007). NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy. Cancer Immunology, Immunotherapy, 56(11):1723-1731.

Bode-Lesniewska, B; Frigerio, S; Exner, U; Abdou, M T; Moch, H; Zimmermann, D R (2007). Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion. Genes, Chromosomes and Cancer, 46(11):961-971.

Schmitt, Anja M; Anlauf, Martin; Rousson, Valentin; Schmid, Sonja; Kofler, Andreas; Riniker, Florian; Bauersfeld, Juliane; Barghorn, Andre; Probst-Hensch, Nicole M; Moch, Holger; Heitz, Philipp U; Kloeppel, Guenter; Komminoth, Paul; Perren, Aurel (2007). WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. American Journal of Surgical Pathology, 31(11):1677-1682.

Mertz, Kirsten D; Demichelis, Francesca; Kim, Robert; Schraml, Peter; Storz, Martina; Diener, Pierre-André; Moch, Holger; Rubin, Mark A (2007). Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. Human Pathology, 38(10):1454-1462.

Ziegler, Annemarie; Seemayer, Christian A; Hinterberger, Marc; Vogt, Peter; Bigosch, Colette; Gautschi, Oliver; Tornillo, Luigi; Betticher, Daniel C; Moch, Holger; Stahel, Rolf A (2007). Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR results. Lung Cancer, 57(3):282-291.

Argani, Pedram; Olgac, Semra; Tickoo, Satish K; Goldfischer, Michael; Moch, Holger; Chan, David Y; Eble, John N; Bonsib, Stephen M; Jimeno, Mireya; Lloreta, Josep; Billis, Athanase; Hicks, Jessica; De Marzo, Angelo M; Reuter, Victor E; Ladanyi, Marc (2007). Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. American Journal of Surgical Pathology, 31(8):1149-1160.

Frigerio, Simona; Padberg, Barbara C; Strebel, Räto T; Lenggenhager, Daniela; Messthaler, Angelika; Abdou, Marie-Therese; Moch, Holger; Zimmermann, Dieter R (2007). Improved detection of bladder carcinoma cells in voided urine by standardized microsatellite analysis. International Journal of Cancer, 121(2):329-338.

Dietel, M; Ellis, I O; Höfler, H; Kreipe, H; Moch, H; Dankof, A; Kölble, K; Kristiansen, G (2007). Comparison of automated silver enhanced in situ hybridisation (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists. Virchows Archiv, 451(1):19-25.

Stadlmann, Sylvia; Gueth, Uwe; Baumhoer, Daniel; Moch, Holger; Terracciano, Luigi; Singer, Gad (2007). Glypican-3 expression in primary and recurrent ovarian carcinomas. International Journal of Gynecological Pathology, 26(3):341-344.

Corsenca, A; Aebersold, F; Moch, H; Bird, P; Weber, M; Hofbauer, G; Wüthrich, R P; Serra, A L (2007). Combined nephrectomy and pre-emptive renal transplantation in a tuberous sclerosis patient with angiomyolipoma, renal carcinoma and life-threatening abdominal haemorrhages. Nephrology, Dialysis, Transplantation, 22(11):3330-3333.

Schmid, Simone; Opravil, Milos; Moddel, Michael; Huber, Milo; Pfammatter, Rahel; Keusch, Gerald; Ambuhl, Patrice; Wuthrich, Rudolf P; Moch, Holger; Varga, Zsuzsanna (2007). Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies. Virchows Archiv, 450(6):665-670.

Zhao, J; Yart, A; Frigerio, S; Perren, A; Schraml, P; Weisstanner, C; Stallmach, T; Krek, W; Moch, H (2007). Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene. Oncogene, 26(23):3440-3449.

Tinguely, Marianne; Jenni, Bettina; Reineke, Tanja; Korol, Dimitri; Kofler, Andreas; Rousson, Valentin; Dommann-Scherrer, Corina; Maurer, Robert; Moch, Holger; Probst-Hensch, Nicole M (2007). Chromosomal translocations t(4;14), t(11;14) and proliferation rate stratify patients with mature plasma cell myelomas into groups with different survival probabilities: a molecular epidemiologic study on tissue microarrays. American Journal of Surgical Pathology, 31(5):690-696.

Thoma, Claudio R; Frew, Ian J; Hoerner, Christian R; Montani, Matteo; Moch, Holger; Krek, Wilhelm (2007). pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nature Cell Biology, 9(5):588-595.

Giger, Olivier T; Lacoste, Elena; Honegger, Christoph; Padberg, Barbara; Moch, Holger; Varga, Zsuzsanna (2007). Expression of the breast differentiation antigen NY-BR-1 in a phyllodes tumor of the vulva. Virchows Archiv, 450(4):471-474.

Huber, Lars C; Brock, Matthias; Hemmatazad, Hossein; Giger, Olivier T; Moritz, Falk; Trenkmann, Michelle; Distler, Jörg H W; Gay, Renate E; Kolling, Christoph; Moch, Holger; Michel, Beat A; Gay, Steffen; Distler, Oliver; Jüngel, Astrid (2007). Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis & Rheumatism, 56(4):1087-1093.

Jäger, Dirk; Filonenko, Valeriy; Gout, Ivan; Frosina, Denise; Eastlake-Wade, Susannah; Castelli, Sandra; Varga, Zsuzsanna; Moch, Holger; Chen, Yao-Tseng; Busam, Klaus J; Seil, Inka; Old, Lloyd J; Nissan, Aviram; Frei, Claudia; Gure, Ali O; Knuth, Alexander; Jungbluth, Achim A (2007). NY-BR-1 is a differentiation antigen of the mammary gland. Applied Immunohistochemistry and Molecular Morphology, 15(1):77-83.

Hinterberger, Marc; Reineke, Tanja; Storz, Martina; Weder, Walter; Vogt, Peter; Moch, Holger (2007). D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation. Modern Pathology, 20(2):248-255.

Zippelius, Alfred; Gati, Asma; Bartnick, Tammo; Walton, Senta; Odermatt, Bernhard; Jaeger, Elke; Dummer, Reinhold; Urosevic, Mirjana; Filonenko, Valeriy; Osanai, Kazuhiro; Moch, Holger; Chen, Yao-Tseng; Old, Lloyd J; Knuth, Alexander; Jaeger, Dirk (2007). Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients. Cancer Immunology, Immunotherapy, 56(2):249-258.

Mihic-Probst, D; Kuster, A; Kilgus, S; Bode-Lesniewska, B; Ingold-Heppner, B; Leung, C; Storz, M; Seifert, Burkhardt; Marino, S; Schraml, P; Dummer, R; Moch, H (2007). Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. International Journal of Cancer, 121(8):1764-1770.

Ceschi, M; Gutzwiller, Felix; Moch, H; Eichholzer, Monika; Probst-Hensch, N M (2007). Epidemiology and pathophysiology of obesity as cause of cancer. Swiss Medical Weekly, 137(3-4):50-56.

Theurillat, J P; Ingold, F; Freitag, C; Zippelius, A; Varga, Z; Seifert, Burkhardt; Chen, Y T; Jäger, D; Knuth, A; Moch, H (2007). NY-ESO-1 protein expression in primary breast carcinoma and metastases - correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration. International Journal of Cancer, 120(11):2411-2417.

Varga, Z; Rageth, C; Saurenmann, E; Honegger, C; von Orelli, S; Fehr, M; Fink, D; Seifert, Burkhardt; Moch, H; Caduff, R (2007). Potentieller Verlust von Metastasen in Sentinel Lymphknoten während der Schnellschnitt Untersuchung. Verhandlungen der Deutschen Gesellschaft für Pathologie, 91:221-224.

2006

Perren, Aurel; Wiesli, Peter; Schmid, Sonja; Montani, Matteo; Schmitt, Anja; Schmid, Christoph; Moch, Holger; Komminoth, Paul (2006). Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient. American Journal of Surgical Pathology, 30(8):1047-1051.

Reineke, Tanja; Jenni, Bettina; Abdou, Marie-Therese; Frigerio, Simona; Zubler, Petra; Moch, Holger; Tinguely, Marianne (2006). Ultrasonic decalcification offers new perspectives for rapid FISH, DNA, and RT-PCR analysis in bone marrow trephines. American Journal of Surgical Pathology, 30(7):892-896.

Varga, Zsuzsanna; Theurillat, Jean-Philippe; Filonenko, Valeriy; Sasse, Bernd; Odermatt, Bernhard; Jungbluth, Achim A; Chen, Yao-Tseng; Old, Lloyd J; Knuth, Alexander; Jäger, Dirk; Moch, Holger (2006). Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases. Clinical Cancer Research, 12(9):2745-2751.

Vogler, Susanne; Pahnke, Jens; Rousset, Sophie; Ricquier, Daniel; Moch, Holger; Miroux, Bruno; Ibrahim, Saleh M (2006). Uncoupling protein 2 has protective function during experimental autoimmune encephalomyelitis. American Journal of Pathology, 168(5):1570-1575.

Bode, Beata; Frigerio, Simona; Behnke, Silvia; Senn, Belinda; Odermatt, Bernhard; Zimmermann, Dieter R; Moch, Holger (2006). Mutations in the tyrosine kinase domain of the EGFR gene are rare in synovial sarcoma. Modern Pathology, 19(4):541-547.

Mertz, K D; Tchinda, J; Küfer, R; Möller, P; Rubin, M A; Moch, H; Perner, S (2006). Cytogenetic alterations in renal tumors. Applications for comparative genomic hybridization and fluorescence in situ hybridization. Der Urologe. Ausg. A, 45(3):316-322.

Tickoo, Satish K; dePeralta-Venturina, Mariza N; Harik, Lara R; Worcester, Heath D; Salama, Mohamed E; Young, Andrew N; Moch, Holger; Amin, Mahul B (2006). Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. American Journal of Surgical Pathology, 30(2):141-153.

Mihic-Probst, D; Mnich, C D; Oberholzer, P A; Seifert, Burkhardt; Sasse, B; Moch, H; Dummer, R (2006). p16 expression in primary malignant melanoma is associated with prognosis and lymph node status. International Journal of Cancer, 118(9):2262-2268.

2005

Lardinois, Didier; Weder, Walter; Roudas, Marina; von Schulthess, Gustav K; Tutic, Michaela; Moch, Holger; Stahel, Rolf A; Steinert, Hans C (2005). Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. Journal of Clinical Oncology, 23(28):6846-6853.

Baker, Patricia M; Moch, Holger; Oliva, Esther (2005). Unusual morphologic features of endometrial stromal tumors: a report of 2 cases. American Journal of Surgical Pathology, 29(10):1394-1398.

Moch, H (2005). Aktuelle Klassifikation der Nierentumoren – Was ist wissenswert für die Praktiker? Praxis, 94(33):1261-1265.

Mazón Peláez, Ignacio; Vogler, Susanne; Strauss, Ulf; Wernhoff, Patrik; Pahnke, Jens; Brockmann, Gudrun; Moch, Holger; Thiesen, Hans-Juergen; Rolfs, Arndt; Ibrahim, Saleh M (2005). Identification of quantitative trait loci controlling cortical motor evoked potentials in experimental autoimmune encephalomyelitis: correlation with incidence, onset and severity of disease. Human Molecular Genetics, 14(14):1977-1989.

Weber, Walter P; Zanetti, Rosanna; Langer, Igor; Dellas, Sophie; Zuber, Markus; Moch, Holger; Remmel, Eugenia; Oertli, Daniel; Wight, Edward; Marti, Walter R (2005). Mammotome: less invasive than ABBI with similar accuracy for early breast cancer detection. World Journal of Surgery, 29(4):495-499.

Langer, Igor; Marti, Walter Richard; Guller, Ulrich; Moch, Holger; Harder, Felix; Oertli, Daniel; Zuber, Markus (2005). Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Annals of Surgery, 241(1):152-158.

Went, Philip; Dirnhofer, Stephan; Salvisberg, Tiziana; Amin, Mahul B; Lim, So D; Diener, Pierre-André; Moch, Holger (2005). Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors. American Journal of Surgical Pathology, 29(1):83-88.

2003

Glatzel, M; Ott, P M; Linder, T; Gebbers, J O; Gmür, A; Wüst, W; Huber, G; Moch, H; Podvinec, M; Stamm, B; Aguzzi, A (2003). Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurology, 2(12):757-763.

This list was generated on Sat Dec 15 03:47:39 2018 CET.